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 ABSTRACT 
Uncoupling proteins (UCPs) constitute a subfamily of mitochondrial inner membrane 
carriers that modulate energy efficiency by regulating membrane proton conductance. One of 
its components, UCP3, is specifically expressed in heart, skeletal muscle and brown adipose 
tissue (BAT). The physiological function of this protein is not clearly established, although it 
seems to play an important role in the control of the production of reactive oxygen species 
(ROS) and in the protection against oxidative stress. UCP3 may also have a function in the 
metabolism of fatty acids. An efficient response to oxidative damage is crucial for cell survival, 
and the transcription factor Nrf2 is a master regulator of the cellular defences against this type 
of stress. In the presence of oxidizing agents or electrophiles, Nrf2 translocates to the nucleus, 
where it induces the transcription of genes involved in the defence against oxidative damage. 
In this work, we have studied the regulation of UCP3 expression and function in response to 
oxidative stress, as well as the possible involvement of Nrf2 in this process. We have found 
that the treatment with hydrogen peroxide (H2O2) or the lipid peroxidation product 4-
hydroxy-2-nonenal (HNE), induces UCP3 expression in cells from mouse heart and skeletal 
muscle. This effect is mediated by the transcription factor Nrf2. Moreover, we have shown that 
the induction of the UCP3 protein is accompanied by an increase in the proton conductance of 
the inner mitochondrial membrane, which results in a decreased production of mitochondrial 
ROS and, consequently, in an increased cell survival. In addition, we have found that both 
UCP3 and Nrf2 have a cardioprotective role in the intact mouse heart subjected to ischemia-
reperfusion (IR), a condition known to increase ROS generation, since mice lacking any of 
these proteins have increased infarct size and augmented levels of creatine kinase compared to 
wild-type mice. Finally, our data strongly suggest that UCP3 is involved in ischemic 
preconditioning (IPC), since the absence of the protein prevents the IPC protective effect 
against IR damage. 
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 RESUMEN 
Las proteínas desacoplantes (UCPs) constituyen una subfamilia de los transportadores de 
la membrana mitocondrial interna que modulan la eficiencia energética mediante la regulación 
de la conductancia de la membrana a los protones. Uno de sus componentes, UCP3, se expresa 
específicamente en el corazón, el músculo esquelético y el tejido adiposo pardo. La función 
fisiológica de esta proteína no está claramente establecida, aunque parece jugar un papel 
importante en el control de la producción de especies reactivas del oxígeno (ROS) y en la 
protección frente al estrés oxidativo. UCP3 también podría tener una función en el 
metabolismo de los ácidos grasos. Una respuesta eficiente frente al estrés oxidativo es esencial 
para la supervivencia celular, y el factor de transcripción Nrf2 es un importante regulador de 
las defensas celulares ante este tipo de estrés. En presencia de agentes oxidantes o electrófilos, 
Nrf2 se transloca al núcleo, donde induce la transcripción de genes implicados en la defensa 
frente al daño oxidativo. En este trabajo hemos estudiado la regulación de la expresión y 
función de UCP3 en respuesta al estrés oxidativo, así como la posible implicación del factor 
Nrf2 en este proceso. Hemos observado que el tratamiento con peróxido de hidrógeno (H2O2) 
o con el producto de la peroxidación lipídica 4-hidroxi-2-nonenal (HNE), induce la expresión 
de UCP3 en células de corazón y músculo esquelético de ratón. Este efecto está mediado por el 
factor Nrf2. Además, hemos mostrado que la inducción de la proteína UCP3 está acompañada 
de un aumento en la conductancia de la membrana mitocondrial interna a los protones, lo que 
resulta en una menor producción de ROS mitocondriales y, por consiguiente, en una mayor 
supervivencia celular. Por otra parte, hemos encontrado que tanto UCP3 como Nrf2 presentan 
un papel cardioprotector en corazones aislados de ratón sometidos a isquemia-reperfusión 
(IR), una condición que incrementa la generación de ROS, puesto que los ratones que carecen 
de alguna de estas proteínas presentan mayor tamaño de infarto y niveles de creatina quinasa 
aumentados en comparación con los ratones de tipo silvestre. Finalmente, nuestros datos 
sugieren que UCP3 está implicada en el precondicionamiento isquémico (IPC), ya que su 
ausencia previene el efecto protector del IPC frente al daño por IR. 
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 INTRODUCTION 
1. MITOCHONDRIAL BIOENERGETICS 
Mitochondria are double membrane organelles with circular genome only present in 
eukaryotic cells. Their main function is the generation of adenosine triphosphate (ATP) by 
oxidative phosphorylation. Mitochondria perform other essential functions including the 
adaptation of cells to metabolic demands during changes in substrate availability (Liesa and 
Shirihai 2013), the control of the generation of reactive oxygen species (ROS) and the cellular 
redox status (Zorov et al. 2014) and the control of cell death (Galluzzi et al. 2012), so that 
mitochondrial dysfunction has emerged as a key factor in pathophysiology (Nunnari and 
Suomalainen 2012). Mitochondria efficiently communicate with the cytosol. The outer 
mitochondrial membrane (OMM) is very permeable, in contrast to the inner mitochondrial 
membrane (IMM), which is highly selective and comparatively impermeable to almost all ions 
and molecules. The mitochondrial carriers (MCs) are special membrane transporters that 
catalyse the transport through the IMM facilitating the exchange of molecules involved in all 
the processes that take part in mitochondrial function (del Arco and Satrústegui 2013, 
Gutierrez-Aguilar and Baines 2013, Palmieri 2014). In humans, the MCs comprise 53 proteins 
of the IMM family of proteins SLC25 (solute carrier family 25). 
1.1. Mitochondrial oxidative phosphorylation 
The most important function of the mitochondrion is the synthesis of ATP by oxidative 
phosphorylation. ATP is used as a main source of chemical energy. Catabolic pathways such as 
the tricarboxylic acid (TCA) cycle, the β-oxidation of fatty acids, and the oxidation of amino 
acids, generate NADH and FADH2 in the mitochondrial matrix. These electron carriers donate 
their electrons to the protein complexes of the electron transport chain (ETC), located within 
the IMM (Fig. I1). The electrons pass along a series of electron carriers to reduce molecular 
oxygen, which acts as the final electron acceptor, to water (Rich and Marechal 2010). The 
energy released as the electrons pass along the ETC drives the endergonic proton pumping 
activities of the respiratory complexes I, III, and IV, which pump protons against their 
electrochemical gradient into the mitochondrial intermembrane space (IMS). This proton 
movement generates potential energy across the IMM in the form of an electrochemical 
gradient of protons or protonmotive force (Δp), which consists of a pH gradient (ΔpH) and an 
electrical potential (ΔΨm). The energy contained in the gradient is used to form ATP from 
adenosine diphosphate (ADP) and inorganic phosphate (Pi). ATP synthesis is carried out by a 
phosphorylation reaction that takes place when protons flow back across the membrane and 
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down their electrochemical gradient through the ATP synthase, by a mechanism known as 
rotary catalysis (Noji et al. 1997, Stock et al. 1999). Thus, the oxidation of substrates is coupled 
to the phosphorylation of ADP, being the electrochemical gradient of protons the connection 
between both processes, as described by Peter Mitchell in his chemiosmotic theory, by which 
he was awarded the Nobel Prize in 1978 (Mitchell 1966, Mitchell 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I1. Diagram showing the mitochondrial electron transport chain which consists of three proton-
translocating complexes (I, III and IV) that act in parallel with respect to the proton circuit and in series with 
respect to the electron flow. (A) Pathway of electron transfer for NADH-linked substrates through complex I. (B) 
Pathway of electron transfer through complex II (succinate dehydrogenase), which reduces ubiquinone (UQ) to 
ubiquinol (UQH2) without translocating protons. Taken from Nicholls and Ferguson, 2013. 
 
1.2. Mitochondrial proton leak 
Oxidative phosphorylation is not fully efficient given the fact that some of the protons 
return to the matrix through alternative leak pathways (proton leak) causing mitochondrial 
uncoupling (Brand 1990). Mitochondria rapidly consume oxygen in the presence of oxidizable 
substrates and ADP to generate ATP (state 3 respiration). By contrast, respiration is slow in the 
absence of ADP (state 4 respiration) and in the presence of the ATP synthase inhibitor 
oligomycin. State 4 respiration can be entirely explained by proton leak across the IMM. The 
proton leak behaves in a non-ohmic manner, which can be evidenced in isolated mitochondria 
as an approximately exponential increase in the proton leak rate (measured indirectly as 
A 
B 
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oxygen consumption) as Δp rises (Fig. I2). Importantly, this behaviour is also evident in intact 
cells, indicating that the proton leak is not caused by damage to the inner membrane during 
the isolation procedure. 
 
 
 
 
 
 
Figure I2. The kinetics of the proton leak (solid line). ΔΨ, mitochondrial membrane potential. 
 
The total proton leak of a mitochondrion can be considered as the sum of two processes: the 
basal leak (i), which is unregulated, and the inducible leak (ii), which is catalysed by specific 
mitochondrial inner membrane proteins and can be activated and inhibited. 
i. Basal proton leak. The mechanism of the basal proton conductance is unclear. Proposed 
mechanisms include the direct movement of protons across the phospholipid membrane (the 
'water wires' model) or their diffusion through or around integral membrane proteins (Nobes 
et al. 1990), as explained below. The contribution of proton conductance through the lipid 
bilayer is only 5% of the total proton leak in rat liver mitochondria (Brookes et al. 1997). There 
is a correlation between mitochondrial proton conductance and the fatty acyl composition of 
the IMM (Brand et al. 2005, Brookes et al. 1998, Hafner et al. 1988, Hulbert et al. 2002, Porter 
et al. 1996). Thus, the content of n−3 polyunsaturates, particularly docosahexaenoate (C22:6, 
n−3), correlates with high proton conductance, and the content of monounsaturates, 
particularly oleate (C18:1, n−9), correlates with low proton conductance. Nevertheless, the 
proton conductance of phospholipid vesicles prepared from mitochondrial lipids is only 2-25% 
of the conductance of the mitochondria they are derived from, and does not vary when the 
composition changes (Brookes et al. 1997, Brookes et al. 1998). Therefore, some other factor 
apart from membrane surface area and phospholipid composition must make an important 
contribution to the basal proton conductance of mitochondria. The magnitude of proton 
conductance also correlates with the abundance of mitochondrial anion carrier proteins, such 
as the adenine nucleotide translocase (ANT) and the uncoupling protein 1 (UCP1). ANT 
catalyses the ADP/ATP exchange across the IMM and is the most abundant protein in 
 
 
20 
 
 INTRODUCTION 
mitochondria. In fact, up to two-thirds of the basal proton leak is attributable to the ANT 
(Brand et al. 2005). Besides, UCP1 contributes to basal proton conductance in BAT (Parker et 
al. 2009), where it is abundantly expressed. Nevertheless, this proposed role for UCP1 is not 
supported by other authors (Shabalina et al. 2010). In both cases (ANT and UCP1), the proton 
leak is not due to protein activity, as it also occurs in the presence of specific inhibitors. Instead, 
it may be a general property of all the mitochondrial inner membrane carrier proteins, but only 
the most abundant make a significant contribution to proton leak, and the interface between 
these proteins and the lipid bilayer may be responsible for the majority of the basal proton leak. 
ii. Inducible proton leak. Inducible proton leak is catalysed by the ANT and UCPs. The 
uncoupling function of the ANT is activated by fatty acids and reactive alkenals, and inhibited 
by carboxyatractylate (Khailova et al. 2006, Parker et al. 2008b). The proton conductance 
catalysed by UCPs is controlled at multiple levels: transcriptional, translational, and 
proteolytic (Azzu and Brand 2010). The uncoupling function of UCPs will be analysed in detail 
in section 2 of the Introduction. 
1.3. The physiological importance of proton leak 
Proton leak may be physiologically important. For instance, the energy consumed by proton 
leak accounts for around 25% of the basal respiration rate of isolated hepatocytes (Nobes et al. 
1990). The contribution of proton leak to metabolic rate in muscle is even greater than that 
observed for isolated liver cells (Rolfe and Brand 1996). Thus, in resting muscle, about 50% of 
metabolic rate is used to counteract the leak of protons into the mitochondrial matrix. Taking 
into account the contribution of liver and skeletal muscle to whole-body resting energy 
consumption, we can estimate that proton cycling in these tissues alone accounts for 
approximately 20% of the standard metabolic rate of the rat (Rolfe and Brand 1996, 1997). 
Therefore, proton leak represents the single most energetically important component of basal 
energy metabolism in the rat. 
2. UNCOUPLING PROTEINS 
Uncoupling proteins (UCPs) belong to the superfamily of mitochondrial anion carriers. 
They are located in the IMM and catalyse nucleotide-sensitive proton leak when activated by 
fatty acids, superoxide, or alkenals derived from membrane lipid peroxidation (Brand et al. 
2004, Esteves and Brand 2005), thus regulating membrane proton conductance (Azzu and 
Brand 2010). The UCP family comprises the proteins UCP1-5, encoded by the genes SLC25A7 
(UCP1), SLC25A8 (UCP2), SLC25A9 (UCP3), SLC25A27 (UCP4), and SLC25A14 (UCP5), all 
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of which have been cloned (Boss et al. 1997, Echtay et al. 2001, Fleury et al. 1997, Nicholls and 
Locke 1984, Yu et al. 2000b). The amino acid sequence identity of UCPs and the ANT proteins 
with UCP1 is shown in Table I1. In the Introduction of this thesis, we will focus on UCP1, 
UCP2 and UCP3 only, as they are the most extensively studied.  
Protein 
UniProt accession 
number 
Amino acid 
identity (%) 
Overlapping 
residues 
UCP1 P25874 100 307 
UCP2 P55851 59 300 
UCP3 P55916 57 311 
UCP5 (BMCP1) O95258 33 282 
UCP4 O95847 30 294 
ANT2 P05141 20 298 
ANT3 P12236 20 298 
ANT1 P12235 19 287 
 
Table I1. Comparison of the amino acid sequence identity of UCPs and the ANT proteins with UCP1. The species 
for all proteins is human. UCP2 and UCP3 have 59% and 57% identity, respectively, with UCP1, and 73% identity 
with each other. Adapted from Krauss et al., 2005. 
 
UCPs exhibit tissue-specific expression: UCP1 is specific of BAT (Bouillaud et al. 1985), 
UCP3 is mainly expressed in cardiac, skeletal muscle and BAT (Boss et al. 1997), and UCP4 
and UCP5 are primarily expressed in the brain (Yu et al. 2000b). UCP2 mRNA, unlike that of 
the rest of the UCPs, is ubiquitously expressed, but its protein has been identified in spleen, 
hypothalamus, pancreatic β-cells, and macrophages (Fleury et al. 1997, Ricquier and Bouillaud 
2000). 
2.1. Physiological role of uncoupling proteins 
In the presence of specific activators, UCPs are able to uncouple substrate oxidation from 
ATP synthesis, allowing protons to return to the mitochondrial matrix and dissipating the 
proton gradient necessary for ATP production. However, in contrast to the well-characterized 
function and regulation of UCP1, the role of UCP2 and UCP3 in the cell is still uncertain. 
Nevertheless, these proteins have been involved in a wide range of physiological processes and 
pathologies, such as insulin resistance, obesity, immunity, neurodegeneration, and 
cardiovascular diseases. 
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2.1.1. Physiological role of UCP1 
UCP1 dissipates Δp to generate heat during non-shivering thermogenesis in BAT from 
hibernators, cold-adapted rodents, and newborn mammals (Cannon and Nedergaard 2004). 
The thermogenic function of the protein is well established and corroborated by the fact that 
UCP1-KO mice are cold-sensitive (Enerback et al. 1997, Nicholls 2001). UCP1 is subjected to 
strict regulation: it is activated by fatty acids and inhibited by purine nucleoside di- and 
triphosphates (Locke et al. 1982). The mechanism by which fatty acids activate the transport 
of protons through UCP1 is still controversial. Two main models have been proposed: 
- Cofactor model. This model proposes that fatty acids act as a prosthetic group in UCP1. 
The carboxylate binds protons and deliver them to a site from which they are translocated to 
the matrix side of the membrane. Thus, UCP1 is a proton carrier and fatty acids increase its 
proton conductance (Rial et al. 1983, Rial et al. 2004, Winkler and Klingenberg 1994). 
- Fatty acid cycling model. Protonated fatty acids flip-flop to the mitochondrial matrix where 
the pH gradient promotes their dissociation into fatty acid anions, which are then 
transported back to the IMS by UCP1, driven by the membrane potential. This cycle leads to 
a Δp net decrease although in this model UCP1 does not translocate protons (Breen et al. 2006, 
Garlid et al. 1998, Skulachev 1991).  
Much of the controversy comes from the use of different experimental systems such as UCP1 
reconstituted into liposomes and isolated mitochondria. Although experimental evidence 
supports both models, the precise molecular mechanism of UCP1 regulation by fatty acids 
remains unresolved. 
2.1.2. Physiological role of UCP2 
The role of UCP2 is still unclear but it seems to be involved in a broad range of physiological 
and pathological processes including cytoprotection (Blanc et al. 2003, Paradis et al. 2003), 
immune cell modulation (Arsenijevic et al. 2000, Rousset et al. 2006) and regulation of glucose 
sensing (Parton et al. 2007, Zhang et al. 2001). 
UCP2 has been reported to uncouple oxidative phosphorylation in thymocytes (Krauss et 
al. 2002) and the INS-1E pancreatic β-cell model (Affourtit and Brand 2008), therefore leading 
to Δp dissipation and to a decrease in ROS production. 
In glucose-sensing cells, UCP2 attenuates insulin secretion, possibly acting in two different 
ways. First, it may act by uncoupling oxidative phosphorylation and lowering the ATP/ADP 
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ratio, which results in decreased stimulation of KATP channels and lowered insulin secretion 
(Chan et al. 2001, Zhang et al. 2001). UCP2 can also act by decreasing ROS production (Krauss 
et al. 2003), which is an important signal in glucose-sensing systems. Accordingly, UCP2 
downregulation or its pharmacological inhibition has been shown to reverse the deleterious 
effects of obesity- and high glucose-induced pancreatic islet dysfunction (Zhang et al. 2006). 
Based on a bioinformatic prediction, UCPs substrates have been proposed to be small 
carboxylic acids or keto acids, transported in symport with protons (Robinson et al. 2008). 
Importantly, the first experimental evidence has been recently reported by Vozza and col., 
showing that UCP2 transports C4 metabolites out of mitochondria, regulating glucose and 
glutamine oxidation (Vozza et al. 2014). 
It is yet uncertain whether UCP2 is also regulated by fatty acids and nucleotides. When 
reconstituted into liposomes, it does catalyse a fatty acid-inducible, nucleotide-sensitive 
proton flux (Zackova et al. 2003), but evidence from isolated mitochondria is diverse. UCP2 
catalyses an inducible uncoupling in the presence of specific activators such as retinoic acid 
analogs (Rial et al. 1999), superoxide (Echtay et al. 2002) and reactive alkenals (Murphy et al. 
2003). 
2.1.3. Physiological role of UCP3 
UCP3 is expressed most abundantly in skeletal muscle and, to a lesser extent, in heart and 
BAT. It was initially suggested that it could mediate thermogenesis in muscle, although 
experimental evidence indicated this not being the case. For example, fasting, a condition 
when energy conservation is required, causes UCP3 upregulation in skeletal muscle (Cadenas 
et al. 1999). Despite upregulation, it does not mediate basal proton leak (Cadenas et al. 1999). 
Moreover, UCP3 knockout (UCP3-KO) mice are not cold-sensitive nor obese, and have normal 
energy expenditure (Gong et al. 2000). UCP3 may play a role in fatty acid metabolism. Several 
conditions associated with a transient rise in plasma free fatty acids (FFA) such as fasting, high 
fat diet, acute exercise, and exposure to cold, markedly increase the Ucp3 mRNA levels (Bezaire 
et al. 2007, Cadenas et al. 1999, Larkin et al. 1997, Schrauwen and Hesselink 2004). Besides, 
UCP3 over-expression has been shown to increase fatty acid transport and oxidation (Bezaire 
et al. 2005). Some authors suggested that UCP3 physiologically functions as a fatty acid 
transporter (Himms-Hagen and Harper 2001, Schrauwen et al. 2006). More recently, however, 
it has been reported that UCP3 is not a fatty acid transporter, although it is required for the 
fasting-induced enhancement of fatty acid oxidation rate and capacity, possibly via mitigated 
mitochondrial oxidative stress (Seifert et al. 2008). Protection from ROS has also been 
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suggested as a putative role for UCP3. This hypothesis is strongly supported by experimental 
evidence. Thus, UCP3 has been reported to neutralise protein oxidation in skeletal muscle 
(Barreiro et al. 2009), and to ameliorate ROS production during exercise (Jiang et al. 2009). 
Moreover, UCP3-KO mice have higher ROS production and oxidative damage (Brand et al. 
2002, Vidal-Puig et al. 2000) and UCP3 over-expressing mice have reduced ROS production 
during aging (Nabben and Hoeks 2008). Furthermore, UCP3 lowers ROS production in 
isolated skeletal muscle mitochondria (Toime and Brand 2010). The observation that 
glutathionylation activates UCP3 and controls proton leak (Mailloux et al. 2013) also suggests 
a role for this protein against oxidative stress. In addition to increased fatty acid oxidation and 
reduced ROS production, UCP3-overexpressing mice also have decreased diet-induced obesity 
and are protected against insulin resistance (Son et al. 2004). Accordingly, mutations in the 
UCP3-encoding gene have also been correlated with obesity and diabetes (de Luis et al. 2012). 
As in the case of UCP2, it is uncertain whether UCP3 is regulated by fatty acids and 
nucleotides. UCP3 does catalyse a fatty acid-inducible, nucleotide-sensitive proton flux when 
reconstituted into liposomes (Zackova et al. 2003), which has also been observed in isolated 
mitochondria (Aguirre and Cadenas 2010, Lombardi et al. 2010). UCP2 and UCP3 may lack the 
amino acid sequence necessary to confer the high sensitivity to fatty acids that is characteristic 
of UCP1 (Jimenez-Jimenez et al. 2006). UCP3 catalyses an inducible uncoupling in the 
presence of specific activators including superoxide (Echtay et al. 2002) and reactive alkenals 
(Murphy et al. 2003). As mentioned above, glutathionylation also activates UCP3 and controls 
proton leak (Mailloux et al. 2013).  
2.2. Regulation of uncoupling proteins expression 
2.2.1. Regulation of UCP1 expression 
The expression of UCP1 varies in response to the adaptive status of the animal: it is high at 
birth but it is repressed afterwards. Recently, it has been recognized that BAT is present in the 
adult human (Cypess et al. 2009). The Ucp1 gene is under extensive transcriptional control 
(Cannon and Nedergaard 2004). Cold-adaptation (or overfeeding under certain conditions) 
leads to the induction of the protein by a mechanism involving the transcriptional coactivator 
PGC-1α (peroxisome proliferator-activated receptor γ coactivator 1α) (Nicholls 2006). In 
response to cold stimulus (or overfeeding), sympathetic inervation in BAT releases 
catecholamines, such as noradrenaline, which activate β3-adrenergic receptors, triggering 
pathways mediated by cyclic AMP (cAMP) that affect Ucp1 transcription. In addition, cAMP-
 
 
25 
 
 INTRODUCTION 
dependent protein kinase A stimulates lipolysis, releasing fatty acids that acutely activate 
UCP1 (Robidoux et al. 2004). FFA also activate a cAMP-responsive enhancer element 
upstream of the Ucp1 gene that controls its expression (Cassard-Doulcier et al. 1993, Kozak et 
al. 1994)  
2.2.2. Regulation of UCP2 and UCP3 expression 
Like UCP1, UCP2 and UCP3 are subjected to extensive transcriptional control. Several 
studies have linked Ucp2 mRNA expression to the hyperglycemia and hyperlipidaemia 
associated with type 2 diabetes mellitus (Chan and Harper 2006). Transcriptional regulation 
has also been linked to fatty acid oxidation (Li et al. 2002), oxidative stress (Giardina et al. 
2008), and Sirt1 protein (Bordone et al. 2006). UCP2 is also translationally regulated, so 
increases in mRNA are not necessarily indicative of increased protein concentration. Ucp2 
mRNA is controlled by glutamine, an amino acid implicated in the insulin secretion pathway 
(Hurtaud et al. 2006). 
Ucp3 mRNA is upregulated in response to nutrient deprivation (Cadenas et al. 1999), serum 
FFA (Samec et al. 1998), cytokines (Busquets et al. 1998), and thyroid hormones (Lanni et al. 
1999, Solanes et al. 2005). Sirt1 represses Ucp3 mRNA expression (Amat et al. 2007). 
Transcriptional upregulation by fatty acids is mediated by peroxisome proliferator-activated 
receptors (PPARs) and the myogenic regulatory factor MyoD (Pedraza et al. 2006, Solanes et 
al. 2003, Villarroya et al. 2007). Moreover, thyroid hormone sensitivity is conferred by a thyroid 
response element (Solanes et al. 2005). 
Like UCP1, UCP2 and UCP3 are also regulated by proteolysis, being rapidly degraded by 
the cytosolic ubiquitin-proteasome machinery with half-lives of a few hours (Azzu et al. 
2010a). 
3. OXIDATIVE STRESS 
Eukaryotic aerobic organisms cannot exist without oxygen, yet oxygen is inherently 
dangerous to their existence (‘oxygen paradox’) (Davies 1995). Oxygen itself is a free radical, 
as it contains two unpaired electrons, and it can give rise to partially reduced oxygen forms 
that are highly toxic. Both free radicals and other non-radical reactive molecules derived from 
oxygen, are collectively known as reactive oxygen species (ROS). To maintain redox 
homeostasis, living cells engage powerful antioxidant systems to eliminate the intracellular 
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ROS (Halliwell 2011). Oxidative stress is caused by an imbalance between the production of 
ROS and the ability of the antioxidant systems to detoxify them. 
Although ROS are usually considered toxic by-products of aerobic metabolism, they play a 
dual role in aerobic cells. On one hand, their uncontrolled production results in oxidative stress 
that impairs cellular function and contributes to the development of cancer, chronic diseases 
and toxicity, potentially triggering cell death (Balaban et al. 2005, Ma 2010), but on the other 
hand, ROS can also be produced in response to physiological cues in a controlled manner. In 
this case, they may serve useful purposes acting as important signalling molecules to regulate 
processes such as cell division, inflammation, immune function, autophagy and stress response 
(Finkel 2011). 
3.1. Mitochondrial ROS production 
ROS are formed physiologically as by-products during respiration (Brand et al. 2004, 
Chance et al. 1979), being the mitochondrial electron transport chain (ETC) the most 
important source (Brand 2010, Brand et al. 2004). Most of the oxygen consumed by a cell is 
reduced to water in a reaction catalysed by the mitochondrial cytochrome c oxidase (complex 
IV), but the mitochondrial ETC contains some redox centres that may transfer one electron 
directly to oxygen generating the superoxide radical (O2·−) (Cadenas and Davies 2000). This 
radical is mainly produced by the transfer of a single electron from complex I or from 
ubiquinone (UQ) of complex III to O2 (Guzy et al. 2005, Murphy 2009). Large amounts of 
superoxide are generated during reverse electron transport from reduced ubiquinone (UQH2) 
to NAD+ at the quinone-binding site in complex I (Brand 2010). Superoxide is a moderately 
reactive radical that leads to the formation of more reactive ROS. Thus, in the mitochondrial 
matrix, O2·− can undergo dismutation by manganese-containing superoxide dismutase 
(MnSOD), producing hydrogen peroxide (H2O2), a stable ‘diffusable’ non-radical ROS. H2O2, 
in turn, can lead to the formation of the hydroxyl radical (·OH), a very dangerous radical due 
to its highly reactivity. H2O2 can react with free transition metals (Fe2+ or Cu+) via the Fenton 
reaction. Thus, ·OH can be generated from an interaction between O2·− and H2O2 (Haber-Weiss 
reaction), as shown below: 
Fe3+ + O2 ·− → Fe2+ + O2 
Fe2+ + H2O2 → Fe3+ + ·OH + OH− (Fenton reaction) 
Net reaction: O2 ·− + H2O2 → ·OH + OH− + O2 
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The rate of mitochondrial ROS generation depends on Δp, the NADH/NAD+ and QH2/Q 
ratios, and the local O2 concentration (Murphy 2009). When the mitochondria are actively 
making ATP (state 3) and consequently have a low Δp and NADH/NAD+ ratio, the extent of 
ROS generation is almost negligible. On the contrary, when there is no ATP synthesis (state 4) 
in conjunction with a high Δp and a highly reduced Q pool, a condition leading to reverse 
electron transport, or when there is a high NADH/NAD+ ratio in the matrix, the production of 
superoxide, predominantly from complex I, is significant (Murphy 2009). 
Few of the ROS produced within mitochondria are released into the cytosol since there are 
several mitochondrial detoxification systems (Wojcik et al. 2010), and the ROS released into 
the cytosol are neutralized by cellular antioxidant systems (Freeman and Crapo 1982). 
Moreover, mitochondria are also able to remove ROS produced by other cellular sources 
(Andreyev et al. 2005). 
3.2. Extra-mitochondrial ROS formation 
Although the main source of ROS is the mitochondrial respiratory chain, nearly all the 
enzymes that utilize O2 as a substrate, including plasma membrane-bound NADPH oxidase 
(NOX), microsomal cytochrome P450 (CYP), and cytoplasmic xanthine oxidase, can produce 
ROS. Indeed, ROS generation has been observed in the cytosol and peroxisomes, as well as in 
plasma and endoplasmic reticulum (ER) membranes. The contribution of extra-mitochondrial 
sources to cytosolic ROS concentration can be relevant in several pathophysiological 
conditions (Andreyev et al. 2005, Jezek and Hlavata 2005, Yu 1994). Thus, even though 
mitochondria is the main source of ROS during ischemia-reperfusion (IR) (detailed in section 
5.1. of the Introduction), experimental evidence suggests an increase in ROS production from 
extra-mitochondrial sources, such as the aforementioned xanthine dehydrogenase/xanthine 
oxidase enzyme system, which was early identified as a potential source of cellular O2·- 
generation during IR (McCord et al. 1985, Schoutsen et al. 1983).  
3.3. Oxidative stress induced by ROS 
Under normal conditions, the effects of ROS are counteracted by a variety of antioxidants. 
As previously stated, oxidative stress is the result of an imbalance of ROS and antioxidants, in 
which the effects of ROS are more potent than the compensatory capacity of antioxidants. An 
excess of ROS can damage the main cellular macromolecules affecting their function, which 
can lead to cellular dysfunction (Sies 1997). Thus, ROS attack polyunsaturated fatty acids in 
membrane phospholipids causing toxic peroxidative reactions (Halliwell and Gutteridge 1990, 
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Kehrer 1993). ROS also damage proteins, altering their functions (Stadtman 2006), and DNA, 
originating DNA strand breaks and mutations (Maynard et al. 2010). ROS can also lead to 
mitochondrial DNA damage, eventually resulting in an impaired ETC (Indo et al. 2007). 
In addition, severe oxidative stress causes an increase in the levels of free cytosolic Ca2+ 
(Orrenius et al. 1989), which can lead to the opening of the mitochondrial permeability 
transition pore (mPTP) and the consequent loss of ΔΨm (Halestrap and Pasdois 2009, Yellon 
and Hausenloy 2007). The subsequent release of cytochrome c from mitochondria leads to the 
execution of cell death processes (Huttemann et al. 2011, Whelan et al. 2010). 
3.4. Amplification of oxidative stress by reactive aldehydes 
As mentioned before, ROS attack the biomembranes causing toxic peroxidative reactions 
which can result in the formation of highly reactive aldehydes (alkenals). The hydroxyl radical 
(·OH) attacks polyunsaturated fatty acids in membrane phospholipids, thereby triggering lipid 
peroxidation. This process results in the generation of lipid hydroperoxides and α,β-
unsaturated aldehydes, including 4-hydroxy-2-nonenal (HNE), one of the most abundant 
hydroxyalkenals produced by lipid peroxidation, and the most cytotoxic, having biological 
effects in the low micromolar range (Benedetti et al. 1984) (Fig. I3).  
 
 
 
 
 
 
 
 
 
 
Figure I3. HNE chemical structure and HNE-induced modulation of cell function. Low physiological levels of 
HNE target cellular pathways for proliferation while maintaining a redox balance. Higher concentrations can be 
detrimental, and chronic exposure to pathological concentrations can lead to apoptosis. Based on Chapple et al. 
2013. 
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HNE results from the oxidation of phospholipids containing ω-6 polyunsaturated fatty acyl 
chains (Spickett 2013). There are several chemical mechanisms that lead to the cleavage of a 
carbon-carbon bond in the fatty acyl chain and ulterior generation of HNE, although the 
process remains unclear. HNE is a bi-reactive compound able to undergo electrophilic 
reactions such as Michael addition and Schiff base formation (Spickett 2013) and can be 
metabolized to less cytotoxic compounds such as 1,4-dihydroxynonene-GSH (DHN-GSH), 
dihydroxynonene-mercapturicacid (DHN-MA) or HNA (Alary et al. 2003, Hill et al. 2009b). 
An important pathway for detoxification of HNE involves the conjugation to the thiol group 
of the antioxidant glutathione by glutathione-S-transferases (GSTA) (Balogh and Atkins 2011). 
Reactive aldehydes like HNE are highly electrophilic and react with proteins and nucleic 
acids, generating various adducts (Conklin et al. 2007). These lipid peroxidation products have 
a very high chemical stability so they can diffuse longer distances than their precursor ROS, 
and therefore they can disseminate oxidative injury and amplify the damage (Esterbauer et al. 
1991). Importantly, the sensing of aldehyde accumulation in injured tissues enables the cell to 
activate a variety of stress resistance pathways and to counteract oxidative stress-mediated 
injury. Therefore, similar to ROS, reactive aldehydes have a dual role, since they may be 
regarded as both toxic products and second messengers that activate protective signalling 
(Balaban et al. 2005, Chapple et al. 2013, Turrens 2003).  
3.5. Cellular antioxidant defences 
ROS-induced damage can be neutralized by antioxidant defences, both enzymatic and non-
enzymatic, which preserve cellular functionality. Antioxidants are normally balanced with 
ROS emission to keep ROS within tolerable limits, preserving their role in signalling processes 
while avoiding their toxic effects. Some of these antioxidant defences are enzymes, such as 
superoxide dismutase (SOD), which catalyses the dismutation of O2·− into O2 and H2O2. There 
are three forms of SOD: cytosolic (Cu/Zn-SOD or SOD 1), mitochondrial (Mn-SOD or SOD 2) 
and extracellular (SOD 3). Some antioxidant enzymes catalyse the reduction of H2O2 into H2O. 
These enzymes are catalase, located in the cytosol and peroxisomes, peroxiredoxin (Prx), 
which requires the thioredoxin (Trx)/thioredoxin reductase (TrxR) system to be regenerated, 
and glutathione peroxidase (GPx), which requires gluthathione (GSH)/gluthathione 
reductase (GSR) to be regenerated (Mari et al. 2009). Both Prxs and GPxs enzymes exist in 
several isoforms that are located differently in either the cytosol or the mitochondria (Hekimi 
et al. 2011). 
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There are several low-molecular-weight molecules such as glutathione (GSH), bilirubin and 
urate, which also form part of the antioxidant system. Some of these molecules (e.g. GSH) act 
as cofactors for antioxidant enzymes. Others, like vitamins C and E, scavenge free radicals. The 
antioxidant system also comprises non-catalytic antioxidant proteins such as glutaredoxins 
(Grxs), metallothioneins (MTs), and Trxs. Redox reactions in cells are enabled by the 
nicotinamide pairs NADP+/NADPH and NAD+/NADH. NADPH is used to reduce oxidized Trx 
(Trx-ox) and glutathione (GSSG) by TrxR and glutathione reductase (GSR), respectively. 
Sulfiredoxin (Srx) reduces oxidized Prx from sulfinic (inactive) to sulfenic (active) acid in an 
ATP and GSH-dependent manner (Nickel et al. 2014). Ultimately, there are DNA repair 
enzymes that remove the DNA lesions (Demple and Harrison 1994) and proteases that degrade 
free radical-damaged proteins (Grune et al. 1995). 
3.6. ‘Mild uncoupling’ as a mechanism to control mitochondrial ROS production 
An exponential correlation between ΔΨm and mitochondrial ROS (H2O2) generation was 
observed in rat heart mitochondria (Fig. I4) (Korshunov et al. 1997).  
 
 
 
 
 
 
 
 
Figure I4. H2O2 formation as a function of ΔΨ. The ΔΨ level was varied by adding different concentrations of the 
uncoupler SF6847 (▪ solid line), malonate (▫) or 100 μM ADP plus 5 mM Pi (  ). Dashed line represents the state 3 
ΔΨ level. Taken from Korsunov et al, 1997.  
 
Based on this observation, some authors suggested that the activation of UCPs or ANT by 
ROS or ROS products, could be protective against oxidative damage by diminishing 
mitochondrial ROS production (Brand 2000, Brand and Esteves 2005, Mailloux and Harper 
2011). The proposed mechanism by which UCP2 and UCP3 decrease mitochondrial ROS 
production is shown in Fig. I5. The ETC produces superoxide (O2·-) that activates UCPs 
(Brunelle et al. 2005, Echtay et al. 2002) and the ANT via the formation of lipid peroxidation 
products such as HNE (Echtay et al. 2003, Murphy et al. 2003). UCP activation allows protons 
 
 
31 
 
 INTRODUCTION 
to return to the mitochondrial matrix independently of the ATPase. This, in turn, causes a 
slight decrease in ΔΨm thereby stimulating respiration, without compromising ATP 
production ('mild uncoupling'). Since ROS production by mitochondria depends greatly on 
ΔΨm, the activation of UCPs would decrease ROS production as a feedback mechanism in 
response to ROS overproduction. 
 
 
 
 
 
 
 
 
 
 
 
Figure I5. During the oxidation of substrates, specific complexes of the ETC reduce O2 to H2O and pump H+ to 
the IMS, generating a proton motive force (Δp). However, some electrons in the reduced complexes also react 
with O2 to produce superoxide (O2·-), which can peroxidize membrane phospholipids, generating HNE, which in 
turn induces H+ transport through UCPs and the ANT. The mild uncoupling caused by this transport, lowers Δp 
and slightly stimulates electron transport, causing the complexes to become more oxidized, and lowering the 
local O2 concentration, effects that decrease O2·- production. Thus, induction of proton leak by HNE limits 
mitochondrial ROS production as a feedback response to overproduction of O2·- by the respiratory chain. Based 
on Echtay et al., 2003. 
 
In fact, UCP2 and UCP3 have been found to catalyse a proton leak that decreases ROS 
emission from mitochondria (Duval et al. 2002, Mailloux and Harper 2011, Negre-Salvayre et 
al. 1997, Toime and Brand 2010). Although there is extensive experimental evidence in favour 
of this hypothesis, some studies do not support it (Nabben et al. 2011, Shabalina and 
Nedergaard 2011). 
4. THE ANTIOXIDANT TRANSCRIPTION FACTOR NRF2 
The nuclear factor erythroid 2-related factor 2 (Nrf2) is a redox-sensitive transcription 
factor that plays an essential role in the cellular defence against oxidative stress. This protein 
is a bZIP transcription factor and a member of the Cap ‘n’ Collar family of regulatory proteins 
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that also includes NF-E2, Nrf1, Nrf3, Bach1 and Bach2 (Motohashi et al. 2002), and mediates 
the cellular response to electrophiles and oxidants (collectively referred to as 'inducers') by 
binding to an enhancer element in the promoter regions of cytoprotective genes (Itoh et al. 
1997). Thus, Nrf2 upregulates the transcription of genes encoding defence enzymes and 
antioxidant stress proteins, such as glutathione S-transferases, NAD(P)H quinone 
oxidoreductase 1 (NQO1), heme oxygenase 1 (HO-1), γ-glutamyl cysteine synthetase (GCS), 
and multidrug resistance-associated proteins (MRP) (Bryan et al. 2013). Nrf2 is activated by 
changes in the redox state of the cell and functions to restore homeostasis by upregulating 
antioxidant, xenobiotic-metabolising, and other cytoprotective enzymes. The Nrf2 knockout 
mice are viable and fertile, but show increased sensitivity to numerous xenobiotics and disease 
conditions associated with oxidative pathology (Motohashi and Yamamoto 2004), 
highlighting the critical importance of Nrf2 in the cellular stress response. Accordingly, 
pharmacological boosting of the Nrf2 activity with chemoprotective agents protect animals 
from oxidative damage (Talalay et al. 2003). 
Nrf2 mRNA is expressed broadly and independently of inducers, which suggests a post-
transcriptional mechanism for Nrf2 activation. In the presence of ROS and xenobiotic agents, 
Nrf2 is translocated to the nucleus where it binds to an antioxidant response element (ARE; 
TGACnnnGCA) in the promoter of a battery of cytoprotective genes (Nguyen et al. 2003, Nioi 
et al. 2003, Rushmore et al. 1991). This activation is controlled by Keap1 (Kelch-like ECH-
associated protein 1), a 624-amino acid protein that contains three main domains: a BTB 
dimerisation domain (Broad-Complex, Tramtrack and Bric a` brac), a cysteine-rich IVR domain 
(intervening region) and a Kelch domain consisting of 6 Kelch repeats through which Keap1 
binds to Nrf2. Keap1 negatively regulates Nrf2 and contains a number of reactive cysteine 
residues that act as the inducer sensors. Thus, inducers chemically react with critical cysteine 
residues of Keap1, leading to stabilisation and nuclear translocation of Nrf2 (Taguchi et al. 
2011). Keap1 is also a substrate adaptor protein for the Cullin3 (Cul3)-containing E3-ligase 
complex, which targets Nfr2 for ubiquitination and degradation by the ubiquitin proteasome 
system (UPS) (Kobayashi et al. 2004). The regulation of Nrf2 by Keap1 is shown in Fig. I6. 
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A        B 
 
 
 
 
 
 
 
 
 
Figure I6. Schematic overview of Nrf2 activation. (A) Basal conditions. Nrf2 is sequestered in the cytosol by a 
Keap1 homodimer which facilitates the ubiquitination and proteasomal degradation of Nrf2. (B) Oxidant 
conditions. A conformational change in Keap1 mediated via its reactive cysteine residues results in the release of 
Nrf2 from Keap1. Nrf2 can no longer be ubiquitinated and degraded, therefore Nrf2 accumulates and translocates 
to the nucleus. There, Nrf2 heterodimerizes with small Maf proteins and binds to the antioxidant response 
element (ARE) of target genes. This activates the expression of genes responsible for eliminating the oxidative 
insult. Based on Bryan et al., 2013. 
 
-  Basal suppression of Nrf2 by Keap1. Keap1 is a cytosolic repressor of Nrf2 that functions as a 
homodimer and plays a central role in regulating the Nrf2 response (Dinkova-Kostova et al. 
2005, Dinkova-Kostova et al. 2002). Under basal conditions (Fig. I6A), Nrf2 is rapidly 
degraded by the proteasome, with a half-life of approximately 20 min. Nrf2 degradation is 
triggered by polyubiquitination through the Keap1/Cul3 ubiquitin ligase complex (Kobayashi 
et al. 2004, Sun et al. 2007). 
-  Oxidant activation of Nrf2 by inducers. Under oxidant conditions (Fig. I6B), Keap1 functions as 
a sensor of stress signals. Thus, the stress-induced oxidation of key cysteine residues of Keap1 
leads to conformational changes of this protein that prevent its binding to Nrf2 and, 
consequently, the degradation of this transcription factor (Fourquet et al. 2010, Yamamoto et 
al. 2008). A variety of chemical inducers, including phytochemicals and derivatives (genistein, 
quercetin, sulforaphane), therapeutics (oltipraz, auranofin), environmental agents (paraquat, 
arsenic), and endogenous compounds (NO, nitro-fatty acids, H2O2 and HNE), modify the 
sensors of Keap1 (Ma and He 2012). As a result, Nrf2 accumulates in the nucleus, 
heterodimerizes with a small Maf protein and binds to an ARE in the promoters of its target 
genes (Malhotra et al. 2010). 
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In addition to cysteine-thiol modification by inducers, several other mechanisms have been 
described to regulate Nrf2 signaling. Keap1-Nrf2 binding can also be prevented in response to 
oxidative stress by proteins such as the autophagy substrate p62 and p53-regulated p21, which 
compete with the interaction between Keap1 and Nrf2, and cause the persistent activation of 
Nrf2 (Chen et al. 2009, Komatsu et al. 2010). Moreover, Nrf2 activation may be also the 
consequence of post-translational modifications of Keap1 that avoid the Keap1-Nrf2 
interaction. Thus, Keap1 phosphorylation at Tyr141 renders the protein highly stable, and its 
dephosphorylation by hydrogen peroxide, an oxidizing agent, results in Keap1 rapid 
degradation and Nrf2 activation. (Jain et al. 2008). Furthermore, the phosphorylation of Nrf2 
at Ser40 by protein kinase C-� (Huang et al. 2002, Niture et al. 2009) and its acetylation by 
CREB-binding protein (Kawai et al. 2011) increase Nrf2 nuclear translocation and the 
transcriptional activation of genes involved in the antioxidant defence. There are also reports 
of Nrf2 phosphorylation via MAPK (mitogen-activated protein kinase) (Yu et al. 2000a). 
Activation of MAPK pathways induces ARE-mediated gene expression via an Nrf2-dependent 
mechanisms, via PI3K/AKT (phosphatidylinositol 3-kinase/protein kinase B) (Kang et al. 
2002), and via PERK (PKR-like endoplasmic reticulum kinase), that mediates Nrf2 nuclear 
import (Cullinan et al. 2003).  
5. CARDIAC ISCHEMIA-REPERFUSION INJURY 
5.1. Cardiac ischemia-reperfusion induces oxidative stress 
Cardiac ischemia is a condition that occurs when the blood flow, and thus oxygen and 
nutrients, is restricted or reduced in an area of the heart. As a consequence, the cardiac tissue 
suffers damage and can even become necrotic, resulting in myocardial infarction. The 
restoration of the blood flow (reperfusion) is essential for recovery; however, a period of 
ischemia followed by reperfusion often leads to increased damage. This is known as ischemia-
reperfusion (IR) injury. 
Mitochondrial ROS generation increases in the myocardium during ischemia (Levraut et al. 
2003, Zweier et al. 1987), and it plays a central role in the pathophysiology of myocardial injury 
(Raedschelders et al. 2012). Under complete anoxic conditions, no ROS are generated (Garlick 
et al. 1987). However, during ischemia there is a progressive reduction in tissue oxygen levels. 
Then, in the presence of reduced levels of O2, the electron transport chain (ETC) malfunctions 
and superoxide formation occurs (section 3.1.). Due to the lack of oxygen, mitochondrial 
oxidative phosphorylation, the major source of cellular ATP production, ceases, which disrupts 
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energy metabolism. There is then a switch to anaerobic glycolysis to compensate for ATP 
generation (Solaini and Harris 2005). Increased glycolysis causes lactic acid accumulation and 
hence a decrease in the intracellular pH.  
When the tissue is reperfused, and given the fact that during reperfusion there is an 
overshoot of oxygen levels, massive ROS production easily occurs (Murray et al. 2004, Zweier 
et al. 1987, Zweier et al. 1989). In this conditions, ROS are mainly produced at complexes I and 
III of the respiratory chain (Drose et al. 2009). The excessive production of ROS is due to high 
ΔΨm values (Huttemann et al. 2008). High amounts of ROS mediate dysfunction of the 
sarcoplasmic reticulum and intracellular Ca2+ overload. The generation of ATP by the re-
energized ETC in the setting of increased cytosolic Ca2+ concentration leads to the opening of 
the mitochondrial permeability transition pore (mPTP) and consequently to the loss of ΔΨm 
(Halestrap and Pasdois 2009). These events induce cardiomyocyte death by hypercontracture, 
which is facilitated during reperfusion by the restoration from acidic to physiological pH 
values (Lemasters et al. 1996, Piper et al. 1998) (Fig. I7). 
 
Figure I7. Mediators of myocardial IR injury. Mitochondrial re-energization (purple), generation of ROS 
(orange), intracellular Ca2+ overload (green), and rapid restoration of physiological pH (blue). Adapted from 
Yellon and Hausenloy, 2007.  
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ROS also mediate myocardial injury by acting as neutrophil chemoattractants. Neutrophils 
accumulate in the infarcted tissue, where they mediate cardiomyocyte death by vascular 
plugging. This causes the release of degradative enzymes, and the generation of ROS, which in 
turn further damage the cell membrane by lipid peroxidation, induce enzyme denaturation, 
and cause DNA damage. Finally, cardiomyocyte death occurs, as the pathways leading to cell 
apoptosis and necrosis are switched on (Galluzzi and Kroemer 2008, Whelan et al. 2010). 
5.2. The phenomenon of ischemic preconditioning 
The heart can be protected against IR injury by undergoing repetitive short non-lethal 
periods of myocardial ischemia and reperfusion prior to a prolonged ischemic period, a 
phenomenon known as ischemic preconditioning (IPC) (Hausenloy and Yellon 2011, Murry et 
al. 1986, Yellon and Downey 2003). The activation of endogenous cytoprotective pathways that 
protect the myocardium against IR injury (conditioning) can be applied before 
(preconditioning), during (perconditioning) or immediately after (postconditioning) the 
ischemic insult, either directly to the heart or to a distal tissue (remote preconditioning) 
(Hausenloy and Yellon 2011, Shi and Vinten-Johansen 2012). A wide range of triggers, 
signalling pathways and potential end-effector mechanisms have been identified (exposed 
below), which appear common to all forms of conditioning. Moreover, conditioning applies to 
not only the cardiomyocyte, but to all the constitutive cell types within the myocardium (Bell 
and Yellon 2012). 
IPC protects the heart by reducing oxidative stress during IR and by inhibiting the opening 
of the mPTP, thus diminishing the shutdown of ATP production and mitochondrial swelling, 
that in turn decreases cellular damage and death by necrosis and apoptosis (Halestrap 2010, 
Javadov et al. 2003). IPC induces two windows of cardioprotection: an immediate phase lasting 
2-3 h (Murry et al. 1986), and a delayed effect 24-48 h later (Kuzuya et al. 1993, Marber et al. 
1993). This latter effect is not as powerful as the previous one but has a longer action. The 
immediate 'classic' IPC involves preformed factors and confers a powerful protective effect 
against myocardial necrosis (Kloner et al. 1998). However, the immediate IPC does not protect 
against the loss of contractility that immediately follows a sub-lethal ischemic insult, called 
'stunning' (Bolli and Marban 1999). The second window of protection is probably related to 
the synthesis of neoformed factors. It protects against myocardial stunning but is less effective 
against necrosis (Bolli et al. 1997, Sun et al. 1995).  
IPC mechanisms are complex and not yet completely understood, but it is known that they 
involve several triggers, mediators and effectors. Brief episodes of ischemia result in the release 
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of initiating factors such as adenosine, bradykinin, norepinephrine, and endorphins (Banerjee 
et al. 1993, Cohen et al. 2001, Liu et al. 1991). During the early phase, these initiators bind to 
specific receptors coupled to G proteins, which results in message transduction. There are two 
identified signalling pathways: the reperfusion-induced salvage kinase (RISK) pathway 
(Hausenloy et al. 2005) and the survivor activating factor enhancement (SAFE) pathway 
(Suleman et al. 2008). Both of these pathways lead to the inhibition of mPTP opening, which 
is considered the main effector of IPC. Mitochondrial ATP-dependent potassium channels 
(mKATP) are also likely effectors of IPC (Gross and Auchampach 1992). For the second window 
of protection, an activation of transcription factors occur. Thus, the activation of the nuclear 
factor-κB (NF-κB) has been reported (Xuan et al. 1999), which induces the expression of 
proteins that provide myocardial protection such as the NO synthase (iNOS) (Shinmura et al. 
2002), and several anti-apoptotic proteins (Stein et al. 2007). 
 5.3. ‘Mild uncoupling’ and cardiac ischemia tolerance 
As explained before, mitochondrial ROS production increases with a higher (more 
negative) ΔΨm. On the contrary, mitochondrial depolarization, which implies a reduction in 
ΔΨm, results in a tighter association between electron transfer and the ETC complexes, thereby 
limiting random electron disassociation and O2·− production (Korshunov et al. 1997). 
Therefore, ‘mild uncoupling’ could be protective against oxidative damage generated during IR 
by diminishing mitochondrial ROS generation. Some studies show that tolerance against IR 
injury is conferred by directly inhibiting the ETC flux with pharmacological agents and 
diminishing ΔΨm (Park et al. 1997). This mechanism is also supported by experiments showing 
modest depolarization after the administration of low concentrations of uncoupling agents 
such as FCCP (carbonyl cyanide 4-p-trifluoromethoxy phenylhydrazone) or DNP (2,4-
dinitrophenol) that evokes protection against ischemic damage in the intact heart (Minners et 
al. 2000) and in cardiomyocytes (Rodrigo et al. 2002), in parallel with a decrease in 
mitochondrial ROS production. Therefore, transient modest mitochondrial depolarization, 
regardless of whether it is achieved via ‘mild uncoupling’, through modulation of the ETC flux, 
or by pharmacological uncoupling, confers protection against IR injury. Hence, the question 
arises as to whether endogenous modulation of mitochondrial uncoupling by UCPs may 
contribute to the regulatory machinery governing cellular ischemia tolerance.  
Taking into account the ‘mild uncoupling’ effect on mitochondrial ROS generation, and 
since UCP2 and UCP3 are expressed in the heart (Bezaire et al. 2007, Murray et al. 2004), it 
seems reasonable to hypothesize that their uncoupling activity could potentially have a major 
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impact on ischemia tolerance and possibly on cardiac ATP production (Cadenas et al. 2010, 
Sack 2006). The activation of UCPs would lower the ΔΨm, thereby attenuating mitochondrial 
ROS production and protecting against oxidative cellular damage (Brand et al. 2004). In fact, 
the ectopic expression of UCP1 in the mouse heart, mitigates reperfusion-induced damage 
(Hoerter et al. 2004).  
Disturbances in ATP synthesis in the heart have been implicated in cardiac failure 
pathogenesis, and increased levels of cardiac UCP2 and UCP3 were found in patients with 
heart failure (Murray et al. 2004). Moreover, in vitro studies have shown that preconditioned 
mitochondria are uncoupled. These mitochondria have lower ΔΨm and reduced ATP levels, and 
their oxygen consumption rates are higher than in non-preconditioned mitochondria (Minners 
et al. 2001). The association of IPC with proton leak has been directly confirmed by measuring 
oxygen consumption and mitochondrial ΔΨm in mitochondria extracted from preconditioned 
rat hearts prior to the onset of a prolonged IR insult (Nadtochiy et al. 2006). Importantly, the 
upregulation of UCP2 and UCP3 was observed in the delayed preconditioned heart (McLeod 
et al. 2005). More recently, the role of UCP3 in cardioprotection against IR injury and the 
induction of IPC has been reported (Ozcan et al. 2013). The mechanism involve the regulation 
of myocardial energetics and ROS generation. 
Another plausible hypothesis for UCP3-mediated cardioprotection could be the 
involvement of this protein in the attenuation of lipotoxic effects. This is based on the fact that 
the ischemic heart is exposed to elevated levels of FFA (Opie and Sack 2002) and that UCP3 
might play a role in the export of fatty acid anions from the mitochondria to prevent the 
accumulation of fatty acid metabolic by-products (Himms-Hagen and Harper 2001). The 
implication of UCP3 in myocardial energetic metabolism has been recently suggested, since 
UCP3 deletion appears to induce a metabolic shift that favoured glycolytic metabolism in a 
mouse model of permanent coronary occlusion (Gargiulo et al. 2014). 
5.4. The Langendorff perfusion system as a tool for the study of the intact mouse heart 
The perfusion system was introduced by Oscar Langendorff in 1895 for the study of the 
mammalian heart physiology, and became a valuable tool for the analysis of factors such as: 
contractile function, coronary blood flow regulation and cardiac metabolism (Langendorff, 
1895). This system is now broadly used for the study of the isolated mammalian heart (ex vivo 
model). In particular, the Langendorff perfusion system is extremely useful for the study of the 
pathophysiology of IR and other disease states. This system is also an essential tool for the 
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study of the impact of pharmacological drugs on heart physiology, as well as for the analysis of 
the consequences of gene deletion or gene expression regulation on intracellular signalling and 
adaption to clinically relevant stressful stimuli (Liao et al. 2012). 
In this ex vivo model, the heart is perfused retrogradely (opposite to normal physiological 
flow) by cannulating the aorta, which implies that the aortic valve closes under pressure, the 
perfusate fills the coronary arterial vasculature, passing through the vascular bed, and being 
drawn off to the coronary sinus into the right atria (Fig. I8). The heart is washed of all blood 
and perfused with buffer solution all throughout. The preparation can be perfused in either 
‘constant flow’ or ‘constant pressure’ modes, depending on specific experimental requirements. 
Each mode has its own advantages and disadvantages that must be taken into account (Bell et 
al. 2011c).  
 
A       B              C           D 
 
 
 
 
Figure I8. Diagrams showing (A) normal physiological flow, (B) normal valve operation, (C) coronary circulation 
(arteries) and (D) coronary circulation (veins). 
 
The use of the Langendorff system has some limitations that have to be considered when 
planning a study. First, the diminutive size and fragility of the mouse heart, as well as its high 
heart rate add technical difficulties to the experiments. Second, and most important, the 
isolation of the heart from the whole animal makes the study less clinically relevant than other 
in vivo approaches (Sutherland et al. 2003). Nevertheless, the procedure offers enormous 
advantages. Thus, as this system provides a tool to study the heart in isolation of other systems 
and out of exocrine control, the experimental measurements are not interfered by those coming 
from other physiological processes. Moreover, it can be used to observe protocols that would 
be lethal to the whole animal if performed in vivo. Another important advantage is that 
treatments and drugs can be used without fear of impacting upon non-cardiac organ function. 
Hence, in summary, the Langendorff perfusion system is an extraordinary tool for the study of 
the physiology of the heart. 
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 OBJECTIVES 
In this thesis, we seek to achieve the following objectives: 
 
1. To determine the effects of oxidative stress on the expression of mitochondrial 
uncoupling protein 3 (UCP3). 
 
2. To analyse the possible involvement of the antioxidant transcription factor Nrf2 on 
UCP3 regulation. 
 
3. To evaluate the influence of UCP3 on mitochondrial function under oxidative stress 
conditions and the possible antioxidant role of this protein. 
 
4. To investigate the potential cardioprotective role of UCP3 and Nrf2 in isolated 
perfused mouse hearts subjected to ischemia-reperfusion, as well as the involvement of 
UCP3 in ischemic preconditioning. 
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1. CELL CULTURE AND TREATMENTS 
1.1. Mouse cardiomyocyte HL-1 cells 
HL-1 cells were grown and maintained on gelatin/fibronectin-coated plates in Claycomb 
medium (Sigma-Aldrich) supplemented with 10% (v/v) fetal bovine serum (Sigma-Aldrich), 
100 μM norepinephrine (Sigma-Aldrich), 1% (v/v) GlutaMAX™ (Gibco, Life Technologies), 
100 U/ml penicillin (GE Healthcare, Little Chalfont, UK) and 100 μg/ml streptomycin (GE 
Healthcare), to maintain a differentiated phenotype and contractile activity. The cells were 
cultured at high confluence and were passed 1:2 every three days.  
1.2. Mouse myoblast C2C12 cells 
C2C12 cells were grown and maintained in Dulbecco’s modified Eagle’s medium DMEM 
(Lonza, Cambridge, UK) containing 4.5 g/L glucose and supplemented with 10% (v/v) fetal 
bovine serum (HyClone™ Thermo Scientific, Rockford, IL, USA), 1 mM sodium pyruvate 
(Sigma-Aldrich), 2 mM L-glutamine (Lonza), 100 U/ml penicillin and 100 μg/ml streptomycin 
(GE Healthcare). The cells were passed 1:4 every two days. For the experiments, C2C12 
myoblasts were differentiated into myotubes after reaching 80-90% confluence, by using for 4 
days DMEM supplemented with 2% (v/v) horse serum (Sigma-Aldrich), 1 mM sodium 
pyruvate (Sigma-Aldrich), 2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. 
1.3. Cell treatments 
For most experiments, the cells were treated with 300 µM hydrogen peroxide (H2O2; Sigma-
Aldrich) for 6 h, or with 20 µM 4-hydroxy-2-nonenal (HNE; Cayman, Ann Arbor, Michigan) 
for 5 h, unless otherwise stated. In some experiments, the antioxidant N-acetylcysteine (NAC; 
Sigma-Aldrich) was added at 5 mM, 1 h before the oxidative challenge. 
2. ANIMALS 
Male UCP3 knockout (UCP3-KO), Nrf2 knockout (Nrf2-KO), and wild-type mice (strain 
background C57BL/6) were bred and housed in the Animal Services Unit of the Centro 
Nacional de Investigaciones Cardiovasculares (CNIC, Madrid, Spain). The animals were 
maintained on normal rodent diet and had ad libitum access to food and water. Experiments 
were performed when mice were 28-30 weeks old. The animals were killed by cervical 
dislocation before quick excision of the heart.  
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All procedures used in this thesis were performed in accordance with the guidelines and 
regulations of the CNIC. 
3. STUDY OF GENE EXPRESSION 
3.1. Determination of RNA expression by quantitative PCR 
3.1.1. RNA extraction 
Total RNA from C2C12 and HL-1 cells was extracted using the TRI Reagent RNA Isolation 
System (MRC, Cincinnati, OH). Cellular samples obtained from 60 mm-plates were lysed and 
homogenized in 1 mL of TRI Reagent using a mortar. The homogenates were then separated 
into aqueous and organic phases by the addition of 200 μL chloroform, vigorous mixing, and 
centrifugation at 12,000 g for 15 min at 4°C. The RNA remained exclusively in the upper 
aqueous phase (600 μL approximately). For RNA precipitation, isopropanol (600 μL) was 
added and the mix was stored for at least 1 h at -20°C. The samples were then centrifuged at 
12,000 g for 10 min at 4°C and the pellet containing the RNA was washed twice with 70% 
ethanol and solubilized in 30-60 μL of RNase-free water for 10 min at 60°C. Finally, the samples 
were frozen at -80°C overnight and then heated at 60°C for 10 min for a better solubilization 
previous to the determination of RNA concentration. 
3.1.2. Determination of RNA concentration and purity 
RNA concentration and purity were determined using a NanoDrop 1000 
Spectrophotometer (Thermo Scientific), from 1 μL of sample. RNA concentration was 
calculated by measuring the absorbance of the sample at 260 nm. 1 OD260 unit at 260 nm 
corresponds to 40 μg/mL of single-stranded RNA. RNA purity was determined by calculating 
the ratio between the absorbance at 260 nm and 280 nm. An Abs260/280 ratio of 2.0 was 
considered “pure” for RNA. 
3.1.3. Reverse transcription 
Reverse transcription (RT) was carried out using the GeneAmp® Gold RNA PCR Core Kit 
(Applied Biosystems, Foster City, CA), with 0.5 µg of total RNA and random hexanucleotides 
as primers (Table M1). The reaction was carried out in a thermocycler, using the following 
cycling parameters:  
10 min at 25°C 
12 min at 42°C 
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RT-PCR buffer 30 mM Tris-HCl, 20 mM KCl pH 8.3 
MgCl2 2.5 mM 
dNTP blend 1 mM (250 μM of each dNTP) 
RNase inhibitor 10 Units 
DTT 10 mM 
Hexanucleotides mix 1.25 μM 
MultiScribe reverse transcriptase 15 Units 
RNase-free H2O Up to 20 μL 
Table M1. Reverse transcription reaction components. 
 
3.1.4. Quantitative real-time PCR 
The resulting cDNA samples (1 μL) were amplified with specific primers, and mRNA levels 
were determined by real-time PCR (RT-PCR) using Power SYBR® Green (Applied 
Biosystems) and the StepONEplusTM Real-Time PCR System (Applied Biosystems). The 
cycling parameters were the following: 
10 min initial denaturation at 95°C 
x 40 cycles: 
15 s denaturation at 95°C 
1 min annealing at 60°C 
 
GENE Forward  Reverse  
Ucp3 5'CTGGAGGAGAGAGGAAATACAGAG3' 5'TGGCATTTCTTGTGATGTTGGGCC3' 
Nrf2 5'GCAAGTTTGCAGGAGCTATTT3' 5'GCTGCTTGTTTTCGGTATTAAGAC3' 
Ucp2 5'GGCCTCTACGACTCTGTC3' 5'GCTCCCGATGCCTGCAT3' 
HO-1 5'ACATCCAAGCCGAGAATGCT3' 5'CCAGGGCCGTGTAGATATGG3' 
HPRT 5'ATTGTAATGACCAGTCAACAGGG3' 5'GCATTGTTTTGCCAGTGTCAA3' 
β-actin 5'CCCAGAGCAAGAGAGG3' 5'GTCCAGACGCAGGATG3' 
Table M2. Specific primer pairs used for the amplification of the analysed genes for quantitative real-time PCR. 
 
The relative gene expression level was calculated using HPRT mRNA or β-actin mRNA as 
housekeeping genes. The sequences of the primer pairs used for the amplification of the 
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analyzed genes are shown in Table M2. The primers were designed using the Primer Express® 
Software 3.0 (Applied Biosystems). 
3.2. Determination of protein expression by immunoblotting 
3.2.1. Cellular fractionation for differential protein extraction 
The following cellular fractionation protocol was based on Fu and Taubman, 2010. Cells 
were scraped from plates in PBS (phosphate-buffered saline; 137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4, 1.8 mM KH2PO4) and centrifuged at 500 g for 5 min at 4°C. The obtained pellet 
was resuspended in buffer 1 (Table M3) and maintained on ice for osmotic lysis for 15 min. To 
proceed with the lysis, the samples were subjected to three freeze/thaw cycles of 5 min 
immersion in liquid N2 followed by 10 min immersion in a water bath at 37°C. Then, the tubes 
were centrifuged at 500 g for 10 min. At this point, pellets (A) and supernatants (B) were 
separated to carry out two different cellular fractionations: 
- The pellets (A), which contain the nuclei, were resuspended in a supplemented 
commercial Radio Immune Precipitation Assay buffer (RIPA; Sigma-Aldrich) (Table M3). The 
samples were maintained on ice for 20 min and centrifuged at 12,000 g for 5 min at 4°C, and the 
obtained supernatants were collected as nuclear protein fractions.  
- The supernatants (B) were collected and spun at 12,000 g for 20 min at 4°C. The final 
pellets (mitochondria-enriched fractions) were resuspended in 30 μl of mitochondrial buffer 
(Table M3). The supernatants were collected as cytosolic fractions. 
 
Buffer 1 Supplemented RIPA buffer Mitochondrial buffer 
EDTA (pH 8.0) 1 mM Glycerol 1% v/v Tris-HCl (pH 7.5) 10 mM 
DTT 1 mM EDTA (pH 8.0) 5 mM Sucrose 320 mM 
NaCl 10 mM Phosphatase inhibitor cocktail EDTA (pH 8.0) 1 mM 
MgCl2 3 mM Protease inhibitor cocktail Protease inhibitor cocktail 
Tris-HCl (pH 7.5) 5 mM 
 Phosphatase inhibitor cocktail 
Protease inhibitor cocktail 
Table M3. Composition of buffers for cellular fractionation. All materials were from Sigma-Aldrich, except the 
phosphatase and protease inhibitor cocktails that were, respectively, PhosSTOP EASYpack tablets and cOmplete Mini 
tablets from Roche (Basel, Switzerland). 
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Protein concentration was determined by the Pierce™ BCA Protein Assay Kit (Thermo 
Scientific). The protein extracts were stored at -80°C.  
3.2.2. Immunoblot analysis 
The desired amount of protein extracts (usually 30-70 μg) was mixed 1:1 (v/v) with Laemmli 
buffer 2X (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromophenol blue and 
0.125 M Tris HCl, pH 6.8; Sigma-Aldrich) and heated at 95°C for 5 min. 
The proteins were separated by electrophoresis, using 10-12% SDS-polyacrylamide gels 
(SDS-PAGE). The gels were usually run at 120 V for 90 min in TGS buffer [25 mM Tris, 192 
mM glycine, 0.1 (w/v) SDS, pH 8.3; Bio-Rad Laboratories, Madrid, Spain]. After 
electrophoresis, the proteins were transferred to nitrocellulose membranes (0.45 μm, Bio-
Rad), usually at 380 mA for 90 min, in transfer buffer [25 mM Tris, 192 mM glycine, pH 8.3, 
plus 20% (v/v) methanol, Bio-Rad], using a Mini-PROTEAN Tetra Blotting Module (Bio-Rad). 
After transfer, the proteins were stained with a Ponceau S solution [0.1% (w/v) from Sigma-
Aldrich, in 5% (v/v) acetic acid] to check protein loading and transfer efficiency. 
 
Antibody Source Dilution Company Reference 
anti-UCP3 Rabbit 1:1000 
Thermo Scientific PA1-055 
Abcam ab3477 
anti-Nrf2 Rabbit 1:1000 
Santa Cruz Biotechnology 
(Santa Cruz, CA) 
sc-13032X 
anti-Porin Mouse 1:7500 Invitrogen 456000 
anti-Lamin A/C Mouse 1:1000 Cell Signalling (Danvers, MA) 2032 
anti-Hsp90 Mouse 1:2000 Santa Cruz Biotechnology sc-13119 
Table M4. Primary antibodies used for immunoblot analysis. Dilutions were made in blocking solution. 
 
For protein immunodetection, the membranes were washed briefly in a TBS-T solution (10 
mM Tris-base, 40 mM Tris-HCl, 150 mM NaCl, adjusted to pH 8.0 and supplemented with 
0.1% Tween 20) and then incubated in blocking solution [5% (w/v) skimmed dry milk in TBS-
T] for 1 h at room temperature. After blocking, the membranes were incubated overnight at 
4°C with the required primary antibody dilution (in 5% milk, TBS-T solution) (Table M4). 
The membranes were then washed 4 times for 10 min with TBS-T, before incubation for 1 h at 
room temperature with a horseradish peroxidase-conjugated secondary antibody dilution (in 
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5% milk, TBS-T solution) (Table M5). The membranes were then washed with TBS-T (4 times 
for 10 min) and the immunoreactive bands were detected using enhanced chemiluminescence 
(SuperSignal® West Femto Chemiluminescent Substrate, Thermo Scientific), following the 
manufacturers’ instructions. The specific band intensity was detected using a CCD camera of 
the ImageQuant LAS 4000 (GE Healthcare). The analysis of the images and the quantification 
of the bands were carried out using the ImageJ (National Institutes of Health, USA) and Image 
Quant 5.2 softwares (Molecular Dynamics, Sunnyvale, CA, USA). 
 
Antibody Source Dilution Company Reference 
anti-rabbit Goat 1:5000 Pierce (Chester, UK) 31460 
anti-mouse Goat 1:8000 Santa Cruz Biotechnology sc-2005 
Table M5. Secondary antibodies used for immunoblot analysis. Dilutions were made in blocking solution.  
 
4. STUDY OF GENE REGULATION 
4.1. Small interfering RNA (siRNA) transfection  
Once HL-1 cells reached 60% confluence, the supplemented Claycomb medium was 
replaced by Opti-MEM® medium (Invitrogen, Carlsbad, CA) to perform the down-regulation 
of Nrf2 and Ucp3 gene expression by small interfering RNA (siRNA). The gene silencers used 
were Nrf2 siRNA (sc-37049 mouse, Santa Cruz) and UCP3 siRNA (sc-42685 mouse, Santa 
Cruz). A non-targeting pool of siRNA or scramble (Scr; Control siRNA-A, sc-37007, Santa 
Cruz) was used as transfection control. HL-1 cells grown in 60 mm-plates were transfected 
with 150 pmol RNAi using 15 μL Lipofectamine® 2000 (Invitrogen), according to the 
manufacturer’s instructions. After 4 h incubation with Lipofectamine® 2000, the Opti-MEM® 
medium was removed from the culture plate and the usual supplemented Claycomb medium 
(section 1.1. of the Materials and Methods) was added. The cells were used for experiments 48 
h after transfection, when silencing was at its maximum. 
 
4.2. Chromatin immunoprecipitation (ChIP) assay 
The protocol used was based on Pescador et al. 2005. HL-1 and C2C12 cells were grown on 
100 mm-plates until they reached 90% confluence. They were exposed to 300 μM H2O2 for 3-6 
h or to 5, 10 or 20 μM HNE for 3 and 6 h. The cells were then fixed for 12 min at 4°C by adding 
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formaldehyde to the culture media to a final concentration of 1% (v/v). The cross-linking was 
stopped by the addition of glycine (0.125 M). The cells were washed with cold PBS and then 
scraped in 0.5 mL of lysis buffer (Table M6). 
Cell lysates were incubated on ice for 10 min and then sonicated to shear the DNA to 
fragments of 200-1500 bp. After removal of the insoluble material by centrifugation at 12,000 g 
for 5 min, 50 μL of each sample were removed and stored (input), while 450 μL were diluted 
in 450 μL of immunoprecipitation buffer (Table M6). 
 
Lysis buffer Immunoprecipitation 
SDS 1% v/v Triton X-100 1% v/v 
EDTA (pH 8.0) 10 mM EDTA (pH 8.0) 2 mM 
Tris-HCl (pH 8.1) 50 mM Tris-HCl (pH 8.1) 20 mM 
Protease inhibitor cocktail NaCl 150 mM 
Table M6. Lysis and immunoprecipitation buffers for ChIP assay.  
 
The lysates were precleared by incubation for 1 h at 4°C with 100 μg of a salmon sperm 
DNA/protein A agarose 50% slurry (Upstate Biotechnology, Lake Placid, NY). The samples 
were then immunoprecipitated twice, initially with whole rabbit serum for 4 h at 4°C 
(Immunoglobulin G, IgG control), and then overnight at 4°C with a rabbit polyclonal anti-
Nrf2 (1:100 dilution; sc-13032X, Santa Cruz). The immunocomplexes were recovered by the 
addition of 200 μg of salmon sperm DNA/protein A agarose 50% slurry to the samples, which 
were then sequentially washed for 15 min in TSE I, TSE II, and Buffer III (Table M7). 
TSE I TSE II Buffer III 
SDS 0.1% SDS 0.1% LiCl 250 mM 
Triton X-100 1% Triton X-100 1% NP-40 1% 
EDTA (pH 8.0) 2 mM EDTA (pH 8.0) 2 mM EDTA (pH 8.0) 1 mM 
Tris-HCl (pH 8.1) 20 mM Tris-HCl (pH 8.1) 20 mM Tris-HCl (pH 8.1) 10 mM 
NaCl 150 mM NaCl 500 mM Deoxycholate 1% 
Table M7. Immunoprecitation buffers for ChIP assay. 
 
Finally, the immunoprecipitated complexes were washed twice with TE buffer (10 mM Tris, 
1 mM EDTA, pH 8.0) and extracted twice with a buffer containing 1% SDS and 0.1 M NaHCO3. 
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The cross-linking was reversed by the addition of 200 mM NaCl (final concentration) and 
overnight incubation at 65°C. 
PRIMERS Forward Reverse 
UCP3 ARE1 
(positive region) 
5'GTATGGTCGCTGTGAAGATCAAAT3' 5'AAGCTTCCATTATGTGCCAAATG3' 
UCP3 ARE3 
(negative region) 
5'TTCCATTCCGTGCCTTCTGT3' 5'GAGGGAACCTCAGGTGATGTTG3' 
Table M8. Quantitative PCR (qPCR) specific primers for ChIP assay.  
 
The proteins were removed by the addition of proteinase K (30 μg/sample) for 2 h at 42°C, 
and the DNA was purified by phenol-chloroform extraction and ethanol precipitation. The 
immunoprecipitated DNA was amplified by qPCR, using the primers described in Table M8, 
which target a highly conserved positive region containing an ARE (antioxidant response 
element) in the Ucp3 promoter, beginning at position −2002 relative to the transcription start 
site (UCP3 ARE1), as well as a negative non-conserved region (UCP3 ARE3).  
4.3. Plasmid construction and cell transfection 
4.3.1. Construction of the pGL4.27-ARE and pGL4.27-mARE plasmids 
Gene-specific oligonucleotides were designed based on the GenBank database for the Ucp3 
5′ flanking region (Accession No. AB011070.1). Forward and reverse single strands of a 71-bp 
fragment of the 5′-upstream region of the Ucp3 gene containing the 9-bp ARE (shown in blue) 
located at the −2002 position in the Ucp3 promoter were designed (Table M9).  
Wild-type (ARE) 
FW 5’-TCGAGTGGTCGCTGTGAAGATCAAATGGGACATTTCTGAAAATGCTTCGCTGGCATTTGGCACATAATGGA-3’ 
Mutant, for negative plasmid control (mARE) 
FW 5’-TCGAGTGGTCGCTGTGAAGATCAAATGGGACATTTCACTAAATTTTTCGCTGGCATTTGGCACATAATGGA-3´ 
Table M9. Oligonucleotides used to construct a DNA fragment containing the ARE or the mutated ARE (mARE). 
 
Specific mutations (shown in red) in the ARE were introduced by site-directed mutagenesis 
using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA), 
following the manufacter’s instructions, to generate the negative plasmid control. 
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Figure M1. pGL4.27 firefly luciferase reporter vector. The restriction sites used to insert the DNA fragment 
containing the ARE are marked in red. 
 
The oligonucleotides for both designs included extensions for the XhoI and HindIII 
restriction sites at their 5′ and 3′ ends, respectively, and were synthesized by Metabion 
International AG (Martinsried, Germany). The synthetic oligonucleotides were annealed, 
phosphorylated, purified, and ligated into the XhoI and HindIII sites of the pGL4.27 firefly 
luciferase reporter vector (Promega Biotech Ibérica) (Fig. M1). The construction was amplified 
using Escherichia coli DH5α cells. Positive clones were selected after DNA digestion followed by 
electrophoresis in 1.5% agarose gel. The resulting clones were named pGL4.27-ARE and 
pGL4.27-mARE. The reporter constructs were confirmed by DNA sequencing performed by 
Secugen S.L. (Madrid).  
4.3.2. Construction of the pGL4.27-Prom and pGL4.27-mProm plasmids 
We defined and cloned a longer DNA fragment (2205 bp, from -2145 to +60 relative to the 
transcription start site) of the Ucp3 promoter (Fig. M2), based on the GenBank database for 
the Ucp3 5′ flanking region (Accession No. AB011070.1). The sequence, containing the ARE, was 
obtained from mouse genomic DNA by PCR, using the primers described in Table M10, which 
were synthesized by Metabion International AG.  
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Forward 5’ AAAGGGGTACCACAGCTGCAAAGAGAACAGAG 3’ 
Reverse 5’ TTCTTTCTCGAGTCCACTCCATTAGGTAGCAGC 3’ 
Table M10. Primers used to clone the Ucp3 mouse promoter fragment. The KpnI (forward) and XhoI (reverse) 
restriction sites are marked in blue.  
 
5’CCATGGACAGCTGCAAAGAGAACAGAGAATGTTCTGGACCATATCAGTGTCCAGCCTGGCTGAGACTGTGGCTCTGGCCTCATCTGGAA
GGCACAGACACGTAGACTCTGGCTTCGTATGGTCGCTGTGAAGATCAAATGGGACATTTCTGAAAATGCTTCGCTGGCATTTGGCACATAATGG
AAGCTTGAGAAATGTCAGCCCTTCCCACTCTTCCTAAGCACCGGGGTGAATTAGAGGCAAGCTCACTGGCTACCCAGAACGCAGAGCACTCCAG
CCTCCCATAAGGGCCATGAACCTTCAGCCAAACCTGCCCCTCAGATCTCTGCTCCTTGAGTGTCACCTTGCAAACCTGCCCAGTCCCTAGCCAG
GGGCTCCCCTTGCCCCAGGCCTTGCCCTCGGCCAGAACAGAGCTTCCAGTACCTGGAGTTCCACGTCCCTCGGGGTAAGAAACCTCTAGGTTCC
AAGCCTAAGGGGTAAAGCCTAGGGTGAAGAAGATCACTGCCAAATCCTGATCCTGTAAATAACCTGAAGGAGTCAAGTGAGAACAGGGCCACAG
GAGGGCACGGGCTGCAGACAAGGTGAAGGTCTGAGACACAGACGACATGCCCAATTTGTTATTTACCAGTCTCTCCCAGTGATAGCTCTGAGGC
AACTTGACTTGCCAAGTTGTACAACACATTTGTCACCACAACCAGAATGAACCCTGACTTCCTTATGCATGCCCTCCACAGATGCCTGGAAAGT
ATTTCTGGTGACCCAGAGACTGTAGCAGCCAACCTTAAAACTCCCAGCAGAGGTTTGACTCTAGCTAGGCCTGAGCTCTCCTCCCTCTGGGTTT
CTCCAGAACCTGCTGCCTCTAGTTTGACTTCTACTTGTAGCCCCAGCCCCCACATGGTTCCCACAGTCCTGCCCATGTCCAGATTAATAGTTCC
AGACTGAGCTCAAAGCAGTGAGCAGGTCCTGGTCCAAGAAACAGGATAGACAGTCTAGATGTCACAGCACCCACCCTGCCATGGCGCTGCGCTC
AAGTTCCAAAATGTCCTCTACCTTCTCTGTCCTACTTATCTCCTCTCCCCTCTCCTTTTAGTTTCCCTTCTATGCCACCTGGCTCCCAACTTCA
GCTGTGCCCACCCAGTCTTTAACCTCAGCGCCTGCAGATGGACCAGCCTACAGTGGTTGCTGCAAGGGATTCTGCTCACCCTGCCCCATCTCCG
GTCCCAGCATGTCCATGTCATGAGGAATCAGGATTGCAGCTGATAGACCCAAAGTGTGGTATAGGTTACAGGCAAGTCAGGCCTGCAGTGACCT
AGCTGTCTGTCCTTGACAGTCAGTTTTCTGTGTAAAGTAAGCATTGACACATGAGGGCTCTACACAGTACGTCAGTGTCTACCGGTACAGTGCA
GTGTGTTAACACCACTGTGAAAGAAACCAGCCACAAGAGGCTATACATTCTATATAATCCTACTCAAACAAAGCATCTAGAACAAGCAAATTAA
GAAGCAGAATAAAGACGAGTGGTTGCCTGAAGCTGGGGGAAGGGAAAGGGGGTGACTTGTTCTGTTTTTGTCTTTGAGCCATGATGAAAGTGTT
CTGAACTAGCATGTAGTAGTTGATCAACCAGACTGTACTAAACACTATTGTGTGCTCTATGTGGGCAAATCACATGCTGTGTACAATACATCTG
TTGTCCTTTGTTTTTAAATTTAGGATCCTGCTTCCTAGAGATGTGGGAAATAGAAGCGCTGTGCCTGAAATATCAAGCATATCTTGGCACCAAG
ATGTCCTCTACCTTCTCTGCCCCGTCTTCTCCTCTCCCCTCTTGAGAATGTCAGGCCTCTAAGAAGTGACACCTGTAACCATTGTATAGGATCC
TGGAGAGCCCCTGTCCTAAGAGACCTTGTCCTTTGGGCTCTCAAAGGTGACAAATGCTGTCACACACCTCCTGGCCACCAAGGTAGCTCTCCTC
TTGAAAGCTCAAAGGAGCCACATTAAAGAGCCCCAGGTCACGGAAGCTAAACCAGATCTGGAACTCACTGGTCCCCTCCCCGCAGCCTGCCTCT
TGTCAAGTGATCAGACTGTCAACTAGCTTCTCAGAATTAGGTTTCAGGTCAGCTGGTGCACAGGGCCAGTGCCGAGCCAGGGACAGCAGAGACA
ACAGTGAATGGTGAGGCCCGGCCGTCAGATCCTGCTGCTACCTAATGGAGTGGAGCCTT 3’ 
 
Figure M2. Cloned fragment (2205 bp) of the Ucp3 promoter region. The sequences shown in magenta and green 
hybridize, respectively, with the Fw and Rv primers used to amplify the whole Ucp3 promoter. The +1 
transcription start site is shown in red, and the transcription direction is indicated by an arrow. The wild-type 
ARE is shown in yellow. 
 
4.3.3. Transient transfection and luciferase reporter assay  
HL-1 cells were cultured in 6-well plates using supplemented Claycomb medium (section 
1.1.). The transfection was carried out when the cells reached 70% confluence, using 
Lipofectamine® 2000, with a 1:1 ratio of DNA (μg) to Lipofectamine® 2000 (μL). The cells from 
each well were transfected with 1.5 μg of one of the reporter vectors (pGL4.27-ARE, pGL4.27-
mARE, pGL4.27-Prom, pGL4.27-mProm, or empty pGL4.27) in a total volume of 150 μl Opti-
MEM® (Invitrogen). As internal transfection control, 30 ng of the Renilla pRL-TK plasmid 
(Promega Biotech Ibérica) were used. For standard promoter activity experiments, transfected 
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cells were incubated for 48 h and then harvested for their use in reporter gene assays. The cells 
were lysed with passive lysis buffer (Promega), and the supernatant was assayed for reporter 
gene activity. The firefly and Renilla luciferase activities were measured using the Dual-
Luciferase Reporter Assay System (Promega) with a GloMax®-Multi Detection System 
(Promega). The ratio between firefly and Renilla luciferase activities from duplicated 
determinations was normalized to that of the empty pGL4.27 vector. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure M3. pGL4.27 firefly luciferase reporter vector. The restriction sites used to insert the PCR products 
containing the cloned promoter fragment are marked in red. 
 
5. DETERMINATION OF OXIDATIVE STRESS AND CELL VIABILITY 
BY FLOW CYTOMETRY 
The fluorescent probes 6-carboxy-2'-7'-dichlorodihydrofluorescein diacetate (DCF-DA; 
C369, Molecular Probes-Invitrogen, Carlsbad, CA) and propidium iodide (PI; P3566, 
Molecular Probes-Invitrogen) were used as indicators of reactive oxygen species (ROS) and 
cell death, respectively. After treatment with 300 μM H2O2 for 3-24 h, C2C12 and HL-1 cells 
were washed with PBS, trypsinized and centrifuged at 335 g for 5 min at room temperature. 
The pellets were resuspended in PBS at a concentration of 106 cells/mL and incubated in the 
presence of 10 μM DCF-DA and 1 µg/mL PI for 30 min at 37°C in the dark. The samples were 
washed twice with PBS and the fluorescence was analysed at excitation/emission wavelengths 
of 485/535 nm for DCF-DA and 536/620 nm for PI, using a FACSCalibur flow cytometer 
(Becton-Dickinson, NJ). 
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6. ANALYSIS OF CELL VIABILITY BY MICROSCOPY 
Viability assays were performed 5-16 h after the treatment with 20 μM HNE, using the 
calcein-AM and propidium iodide (PI) method for simultaneous fluorescence staining of viable 
and dead cells. HL-1 cultures were stained for 15 min in the dark with 1 µM calcein (CA; 
C3100MP, Molecular Probes-Invitrogen) and 2 µM PI (P3566, Molecular Probes-Invitrogen). 
The cells were then analysed using an Axiovert 200 epifluorescence Microscope (Zeiss) 
coupled to a monochrome-colour CCD camera, and 4 images were taken for every treatment 
using a 10X dry objective in red and green channels. Finally, red (PI positive) and green (calcein 
positive) cells were counted in 4 fields per treatment and condition, and a dead/total cell 
percentage was calculated and compared between conditions. 
7. MEASUREMENT OF CELLULAR RESPIRATION 
Oxygen consumption in HL-1 cells was measured using an XF24 Extracellular Flux 
Analyser (Seahorse Bioscience, North Billerica, MA) after silencing as described in section 4.1. 
To obtain a homogeneous monolayer of cells, 80,000 transfected cells per well were plated in 
XF24 cell culture microplates (Ref.100850-001, Seahorse Bioscience) the day before the 
experiment. 
To study the effect of H2O2 and HNE on cell respiration, the experiments were performed 
as follows. HL-1 cells were exposed to 300 µM H2O2 for 3 h. The cells were then incubated in 
unbuffered DMEM supplemented with 25 mM glucose, 1 mM pyruvate and 2 mM glutamine, 
and the cells were incubated at 37°C in a CO2-free incubator for 1 h for equilibration before the 
experiment. For HNE experiments, HL-1 cells were exposed to 20 µM HNE for 4 h and then, 
the Claycomb medium was replaced by supplemented unbuffered DMEM. In this case, the 
HNE treatment was maintained in the unbuffered DMEM medium. The cells were incubated 
at 37°C in a CO2-free incubator for 1 h. An overnight-equilibrated calibration cartridge 
(Ref.100777-004, Seahorse Biosciences) was then loaded with unbuffered DMEM (port A), 5 
μg/mL oligomycin (port B), 300 nM FCCP (carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone; port C), and 1 µM antimycin A plus 1 µM rotenone (port 
D), all obtained from Sigma-Aldrich. This allowed determination of the basal respiration, the 
amount of oxygen consumption linked to ATP production, the proton leak, the maximal 
respiration capacity, the reserve capacity, and the non-mitochondrial oxygen consumption. In 
all experiments, the protein concentration in each well was determined at the end of the 
measurements, using the Pierce™ BCA Protein Assay Kit (Thermo Scientific) after cell lysis in 
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RIPA buffer (Sigma-Aldrich) supplemented with protease inhibitor cocktail (cOmplete Mini 
tablets from Roche), and was used to calibrate the oxygen consumption data. 
8. ISOLATED HEART PERFUSION EXPERIMENTS 
8.1. Langendorff perfusion of isolated hearts 
Mice were killed by cervical dislocation, and the hearts were immediately excised, rinsed, 
and arrested in ice-cold Krebs-Henseleit buffer solution (Table M11). The hearts were then 
cannulated via the aorta (Ø = 0.8 mm cannula), and perfused retrogradely with warm (37°C) 
Krebs-Henseleit buffer using a Langerdorff setup. 
 
Krebs-Henseleit buffer solution 
NaCl 120 mM 
NaHCO3 25 mM 
Glucose 11 mM 
KH2PO4 1.2 mM 
MgSO4 1.2 mM 
KCl 4.8 mM 
CaCl2 2 mM 
   Table M11. Krebs-Henseleit buffer solution composition. 
 
The system (Fig. M4 and Fig. M5) consisted of a peristaltic pump (REGLO Digital MS-4/8, 
ISMATEC International, Wertheim, Germany), a pressure transducer (CIBERTEC S.A., 
Madrid, Spain), a pressure transducer amplifier (CIBERTEC), and a circulating water bath 
(Digiterm 100, JP Selecta). The glassware was kindly provided by Prof. M. Saadeh Suleiman 
(University of Bristol, Bristol, UK). Recordings were obtained using a PowerLab 2/20 
(ADInstruments, Oxfordshire, UK) and the PowerLab Chart software (ADInstruments). 
The heart was immersed at all times in perfusion solution (Krebs buffer) that was kept at 
37°C via water jackets. The solution was previously bubbled with 95% O2/5% CO2 to maintain 
pH 7.4.  
 
 
 
60 
 
 MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure M4. The Langendorff setup used for the experiments described in this thesis. 
 
 
Figure M5. (A) Silk suture was used to secure the cannulated mouse heart and ensure placement. (B) The heart 
during perfusion, immersed in warm Krebs buffer. (C) The pressure transducer (circled in red) to monitor 
perfusion pressure was set just above the aortic cannula. (D) The peristaltic pump controls the perfusion flow. 
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The aortic pressure was monitored continuously by a pressure transducer located above the 
cannula (Fig. M5C). For cannulation, the flow was set at 0.8 mL/min. At the beginning of the 
stabilization, the flow was manually increased in order to build up pressure to approximately 
70 mmHg. The flow necessary to achieve this aortic pressure varied between experiments, but 
was usually 1.5-2.5 mL/min. For exclusion criteria, all experiments in which the flow was lower 
than 1 mL/min or higher than 3 mL/min were discarded. The flow was then maintained 
constant throughout the experiment. 
8.2. Experimental perfusion protocols 
Once the hearts were securely attached to the cannula and successfully beating, different 
perfusion protocols were applied, as described below (schematically depicted in Fig. M6): 
- Control (C): hearts were perfused with standard oxygenized Krebs solution at 37°C for 120 
min. 
- Ischemia (I): hearts were allowed to stabilize for 20 min before the flow was completely 
stopped to generate global normothermic ischemia for 40 min. 
- Ischemia-reperfusion (IR): hearts were allowed to stabilize for 20 min before generating global 
normothermic ischemia for 40 min. Then, the flow was restored and the hearts were reperfused 
for 60 min. 
- Ischemic preconditioning control (IPC+C): hearts were allowed to stabilize for 20 min before 
applying 2 cycles of 5 min global normothermic ischemia plus 5 min reperfusion. Then, they 
were perfused for 60 min. 
- IPC+I: hearts were allowed to stabilize for 20 min before 2 cycles of 5 min global 
normothermic ischemia plus 5 min reperfusion. Then, they were subjected to a 40 min period 
of ischemia. 
- IPC+IR: hearts were allowed to stabilize for 20 min before 2 cycles of 5 min global 
normothermic ischemia plus 5 min reperfusion. Then, they were subjected to a 40 min period 
of ischemia followed by 60 min of reperfusion. 
During the perfusion experiments, the aortic pressure was continuously monitored. As 
shown in Fig. M7, a sharp drop was observed at the beginning of ischemia when the flow is 
stopped, which was restored at reperfusion. 
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Figure M6. Diagrams showing the perfusion protocols performed for the Langendorff experiments. 
 
Upon completion of the perfusion protocols, the hearts were either removed off the cannula, 
the ventricles rapidly frozen in liquid nitrogen, and stored at -80°C until processing for analysis 
of protein expression (section 8.3.), or subjected to triphenyltetrazolium chloride (TTC) 
staining for infarct size measurements (section 8.4.) 
A 
B 
Figure M7. Representative recordings of the aortic pressure (mmHg) during 35 min showing the beginning of 
ischemia after (A) stabilization, and (B) an IPC protocol. The aortic pressure drops to minimum when the flow is 
stopped for an ischemia period. Recordings were obtained using a PowerLab Chart software (ADInstruments). 
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8.3. Tissue protein extract preparation 
Frozen hearts were finely minced with sharp scissors in supplemented RIPA buffer (6 mL/g 
heart tissue, Table M12), and then lysed on ice for 25 min. The lysates were separated into two 
equal parts to obtain total and nuclear cellular fractions. 
Supplemented RIPA buffer 
DTT 1 mM 
Pefabloc 1 mM 
Phosphatase inhibitor cocktail 
Protease inhibitor cocktail 
 
Table M12. Supplemented RIPA buffer for heart protein extraction. All materials were from Roche, except RIPA 
and DTT that were from Sigma-Aldrich. 
  
A) For total extracts, the lysates were centrifuged at 12,000 g for 10 min at 4°C. The 
supernatants were collected and stored at -80°C. 
B) For nuclear extracts, the lysates were centrifuged at 500 g for 10 min at 4°C. The 
supernatants were discarded and the pellets were resuspended in 50 μL supplemented RIPA 
buffer and allowed to lyse for another 10 min on ice. Afterwards, the samples were centrifuged 
at 12,000 g for 10 min at 4°C, and the supernatants were collected as nuclear extracts and stored 
at -80°C. 
Protein concentration was determined by the Pierce™ BCA Protein Assay Kit (Thermo 
Scientific). UCP3 and Nrf2 protein expression levels were analysed by immunoblot as 
previously described (section 3.2.2.). 
8.4. Infarct size measurements 
For infarct size measurements, perfused hearts were stained with 2,3,5-
triphenyltetrazolium chloride (TTC; Sigma-Aldrich). Upon completion of the experimental 
perfusion protocol, 1% TTC in PBS was perfused through the cannula at 1 mL/min for 12 min 
at 37°C. The heart was then removed from the cannula, immersed in PBS and kept at 37°C for 5 
min. Afterwards, the heart was wrapped in cling film, frozen at -20°C for 30 min, and cut into 
6-7 slices (approximately 2 mm thick). The slices were fixed overnight in 4% formaldehyde, 
washed with water, photographed by both sides, allowed to dry for 24 h over desiccant paper, 
and weighted. 
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TTC is a white crystalline powder that works as a redox indicator, since it is enzymatically 
reduced to red TPF (1,3,5-triphenylformazan) in living tissues due to the activity of several 
dehydrogenases, while it remains white in areas of necrosis (Fig. M8). 
 
 
 
 
 
 
 
Figure M8. TTC structure in both oxidized and reduced states. 
. 
The images were analysed for infarct size using AlphaEaseFC software (Alpha Innotech, 
San Leandro, CA). The percentage of infarcted volume of the whole heart was calculated taking 
into account the images from both sides of each slide, and the contribution of each particular 
slice to the total dried weight of the heart. 
8.5. Creatine kinase activity assay 
Creatine kinase levels in the coronary effluent were measured to determine reperfusion 
injury. CK is primarily found in muscle, brain and heart tissue. The determination of CK 
activity provides a sensitive marker for the diagnosis of myocardial infarction. Aliquots of 
coronary effluent were collected prior to ischemia for basal levels, and during reperfusion. The 
samples were maintained at 4°C and analysed for CK activity on the same day of the 
experiment. It is worth noting that there was a “dead volume” in the perfusion chamber that 
delays the release of effluent. This “dead volume” was measured at the end of the experiment, 
when all the effluent that remains in the chamber was manually released, and it was taken into 
account for the calculation of the total effluent volume.  
CK activity in the effluent was determined by the CK-NAC kit (CK113, Randox, Belfast, 
UK). The determination of CK activity was made by using creatine phosphate and ADP as 
substrates (Fig. M9). The enzyme is very unstable due to the oxidation of sulphydryl groups 
in its active site, and for this reason NAC is included in the test. The absorbance of samples 
was measured at 340 nm every 1 min for 4 min at room temperature, and the absorbance 
increment (ΔAbs) was registered. For calculation, the following equation was used following 
manufacter’s instructions: CK activity (units/L)= 4127 x ΔAbs (at 25°C). To estimate total CK 
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release, the area under the curve (AUC) was calculated using the trapezium rule (Abdul-Ghani 
et al. 2014). 
 
Creatine phosphate + ADP   Creatine + ATP 
 
Glucose + ATP    Glucose-6-P + ADP 
 
Glucose-6-P + NADP+   Gluconate-6-P + NADPH + H+ 
 
Figure M9. Principle for the creatine kinase (CK) activity measurement with the CK-NAC Randox kit. The 
determination of CK was made by using creatine phosphate and ADP as substrates for faster reaction and 
improved sensitivity than the use of creatine and ATP. 
 
9. STATISTICAL ANALYSIS 
The data are presented as mean ± SEM. The statistical significance of the differences 
between means was calculated using a two-tailed Student t test or one-way ANOVA followed 
by a Tukey post hoc test. A P value < 0.05 was considered statistically significant. 
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PART I. STUDY OF UCP3 EXPRESSION AND FUNCTION UNDER 
OXIDATIVE STRESS. ROLE OF THE TRANSCRIPTION FACTOR NRF2 IN 
OXIDATIVE STRESS-MEDIATED UCP3 UPREGULATION 
 
1. EFFECTS OF HYDROGEN PEROXIDE (H2O2) ON UCP3 
EXPRESSION AND FUNCTION 
1.1. Effects of H2O2 on UCP3 expression and Nrf2 nuclear accumulation 
UCP3 has been proposed to protect against oxidative damage (Brand and Esteves 2005, 
Mailloux and Harper 2011). To investigate whether UCP3 expression was regulated in 
response to oxidative stress, we first studied UCP3 expression after hydrogen peroxide (H2O2) 
treatment in two different cell lines: C2C12, a mouse myoblast cell line, and HL-1, a mouse 
cardiomyocyte cell line. Moreover, we analysed the nuclear accumulation of the antioxidant 
transcription factor Nrf2 under the same challenging conditions. 
1.1.1. H2O2 treatment increases oxidative stress but does not induce cell death at short 
exposure times 
To induce oxidative stress, we treated C2C12 and HL-1 cells with 300 μM H2O2 for 3, 6 or 
24 h. The extent of oxidative stress was determined by analysing DCF-DA fluorescence by flow 
cytometry. The fluorescence signal increased significantly after a 6 h exposure to H2O2 in both 
C2C12 and HL-1 cell lines (Fig. R1), indicating enhanced oxidative stress levels. 
Cell death was determined by incorporation of propidium iodide (PI), which was also 
analysed by flow cytometry (Fig. R2). Our data showed that the treatment with 300 μM H2O2 
for up to 24 h did not significantly increase cell death in C2C12 cells, as the fluorescence 
intensity was not modified (Fig. R2A). However, a significant increase in cell death was 
observed after 24 h of H2O2 treatment in HL-1 cells, but not after 3 or 6 h exposure (Fig. R2B). 
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Figure R1. Time-dependent oxidative stress induced by H2O2 treatment. Oxidative stress was determined by 
flow cytometry (upper panels) using the fluorescent probe dichlorofluorescein diacetate (DCF-DA) in (A) C2C12 
and (B) HL-1 cells treated with 300 μM H2O2 for 3 to 24 h. The percentages of positive cells are indicated. 
Histograms (bottom panels) show the mean ± SEM of the ROS levels relative to the basal conditions from 6-8 
independent experiments. C, control untreated cells. *P < 0.05, ***P < 0.001. 
 
Accordingly, the estimation of apoptotic cells, as determined by analysis of cleaved caspase 
3 expression levels, was not altered in C2C12 cells but increased in HL-1 cells at 24 h (Fig. R3). 
These results allowed us to establish the timing conditions under which H2O2 treatment 
caused oxidative damage but not cell death. 
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Figure R2. Time-dependent cell death induced by H2O2. Flow cytometry analysis of propidium iodide (PI) 
incorporation by (A) C2C12 and (B) HL-1 cells treated with 300 μM H2O2 for 3, 6 or 24 h. Histograms show the 
means ± SEM of cell death compared to the basal conditions from 6-8 independent experiments. C, control 
untreated cells. **P < 0.01. 
 
A       B 
 
 
Figure R3. Time-dependent apoptotic cell death induced by H2O2. Representative immunoblots of caspase 3 
protein in cytosolic extracts from (A) C2C12 and (B) HL-1 cells exposed to 300 μM H2O2 for 3, 6 or 24 h. Tubulin 
was used as protein loading control. C, control untreated cells. 
 
1.1.2. H2O2 treatment upregulates UCP3 expression 
We next studied the effects of H2O2 treatment on UCP3 expression in C2C12 and HL-1 cells. 
As shown in Fig. R4A and B, the exposure to 300 μM H2O2 for 3 or 6 h significantly increased 
UCP3 protein levels in the mitochondrial fraction of C2C12 and HL-1 cells. A more detailed 
time-course experiment (Fig. R4C) showed that the observed increase in UCP3 levels was not 
immediate but required 3 h to become significant. 
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Figure R4. Effects of H2O2 on UCP3 expression levels. (A, B) Representative immunoblots and histograms of 
UCP3 protein levels in mitochondrial extracts from (A) C2C12 and (B) HL-1 cells exposed to 300 μM H2O2 for 3 
or 6 h. (C) Representative immunoblot and histogram of a time-course experiment to analyse UCP3 protein levels 
in mitochondrial extracts from C2C12 cells exposed to 300 μM H2O2 (15 min-6 h). Porin was used as 
mitochondrial protein loading control. Histograms show the means ± SEM from 7-8 independent experiments. C, 
control untreated cells. *P < 0.05, **P < 0.01, ***P < 0.001.  
 
To study whether these elevated UCP3 protein levels after H2O2 treatment correlated with 
an increase in Ucp3 gene expression, we analysed Ucp3 mRNA levels under the same oxidative 
stress conditions. Supporting the protein expression data, the mRNA levels of Ucp3 were 
slightly but significantly increased by 300 μM H2O2 treatment at 3 and 6 h in both cell lines 
(Fig. R5). We also studied the mRNA levels of Ucp2, the other UCP expressed in skeletal 
muscle and heart, and found that they remained unaffected in both C2C12 and HL-1 cells (Fig. 
R5). These results indicate that the enhanced Ucp3 expression after H2O2 treatment is a specific 
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response. Therefore, the elevated UCP3 protein levels can be explained, at least in part, by an 
increase in the expression of the Ucp3 encoding gene. Taken together, these results indicate 
that UCP3 expression is upregulated in response to oxidative stress. 
A            B 
 
 
Figure R5. Effects of H2O2 on Ucp2 and Ucp3 mRNA levels. mRNA levels of Ucp2 and Ucp3 in (A) C2C12 and 
(B) HL-1 cells exposed to 300 μM H2O2 for 3 or 6 h. HPRT and β-actin were used as housekeeping genes for internal 
normalization Histograms show the means ± SEM from 9 (C2C12) and 6 (HL-1) independent experiments. C, 
control untreated cells. *P < 0.05, **P < 0.01. 
 
1.1.3. H2O2 treatment induces nuclear accumulation of the transcription factor Nrf2 
The transcription factor Nrf2 is a master regulator of the antioxidant response in the cell 
(Jaiswal 2004, Kobayashi et al. 2006). It is known that this protein accumulates in the nucleus 
after an oxidative insult and then promotes the transcription of several genes involved in the 
defence against oxidative damage (Ishii et al. 2002, Itoh et al. 1999). It could be expected that, 
upon H2O2 treatment, Nrf2 would also accumulate in the nucleus of the cell lines we used. Figs. 
R6A and B show that Nrf2 accumulation was indeed observed in the nuclear fraction of both 
C2C12 and HL-1 cells after 3 and 6 h exposure to 300 μM H2O2. This increase was significant 
at 1 h and was also time dependent (Fig. R6C).  
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Figure R6. Effects of H2O2 on Nrf2 expression levels. (A, B) Representative immunoblots and histograms of 
Nrf2 protein levels in nuclear extracts from (A) C2C12 and (B) HL-1 cells exposed to 300 μM H2O2 for 3 or 6 h. 
(C) Representative immunoblot and histogram of a time-course experiment to analyse Nrf2 protein levels in 
nuclear extracts from C2C12 cells exposed to 300 μM H2O2 for 15 min to 6 h. Lamin A/C and Hsp90 were used as 
nuclear protein loading controls. Histograms show the means ± SEM from 8 independent experiments. C, control 
untreated cells. *P < 0.05, **P < 0.01, ***P < 0.001. 
 
Consistently, there was an increase in Nrf2 mRNA in H2O2-treated C2C12 and HL-1 cells, 
which paralleled that of its target gene HO-1 (Fig. R7). Therefore, Nrf2 accumulates in the 
nucleus of both C2C12 and HL-1 cells under oxidative stress conditions.  
 
 
 
 
 
 
75 
 
 RESULTS 
A             B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure R7. Effects of H2O2 on Nrf2 and HO-1 mRNA levels. mRNA levels of Nrf2 and HO-1 in (A) C2C12 and 
(B) HL-1 cells exposed to 300 μM H2O2 for 3 or 6 h. HPRT and β-actin were used as housekeeping genes for internal 
normalization. Histograms show the means ± SEM from 9 (C2C12) and 6 (HL-1) independent experiments. C, 
control untreated cells. *P < 0.05, **P < 0.01, ***P < 0.001. 
 
1.2. Involvement of Nrf2 in H2O2-induced UCP3 upregulation 
1.2.1. Nrf2 binds to the Ucp3 promoter after H2O2 treatment 
Since the antioxidant transcription factor Nrf2 accumulates in the nucleus of H2O2-treated 
C2C12 and HL-1 cells in parallel with the increase in the UCP3 protein in mitochondria, we 
tested the possibility that Nrf2 could regulate UCP3. First, we investigated the possible 
binding of Nrf2 to the Ucp3 promoter under oxidative stress. For this, we identified and defined 
in the Ucp3 promoter a highly conserved region containing an ARE (antioxidant response 
element) and beginning at position −2002 relative to the transcription start site. We also 
defined a non-conserved ARE region that was used as a negative control (Fig. R8).  
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Figure R8. Identification of a conserved ARE within the Ucp3 promoter. Schematic representation of the 
mouse Ucp3 gene showing the nucleotide sequences matching the consensus antioxidant response element (ARE) 
from six mammalian species within the positive region and a non-conserved ARE within the negative region, as 
analysed by ChIP assay. 
 
We then analysed the potential binding of Nrf2 to the Ucp3 promoter by a ChIP assay. Using 
this technique, we found that Nrf2 binds to the ARE region of the Ucp3 promoter in C2C12 
cells after treatment with H2O2 for 3 or 6 h (Fig. R9A) and in HL-1 cells after a 6 h exposure 
(Fig. R9B). These data suggested that the enhanced UCP3 expression induced by H2O2 
treatment may be due to Nrf2 binding to the Ucp3 promoter.  
A       B 
 
Figure R9. ChIP assay of Nrf2 binding to the Ucp3 promoter after H2O2. ChIP assay of Nrf2 binding to the 
mouse Ucp3 promoter in (A) C2C12 and (B) HL-1 cells exposed to 300 μM H2O2 for 3 or 6 h. RT-PCR 
quantification and enrichment of positive and negative regions after immunoprecipitation with Nrf2 or control 
IgG antibodies are shown. Histograms show the means ± SEM from 3 independent experiments. C, control 
untreated cells. *P < 0.05, **P < 0.01. 
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1.2.2. H2O2-induced UCP3 upregulation is mediated by Nrf2 
Next, we examined whether the binding of Nrf2 to the Ucp3 promoter induced the 
transcription of the Ucp3 gene and the subsequent increase in UCP3 protein levels. For this, we 
conducted luciferase reporter assays in HL-1 cells. To perform these experiments the cells were 
transfected with a plasmid (pGL4.27) containing a 71 bp fragment of the Ucp3 promoter, which 
included either the ARE or a mutated ARE (mARE) upstream of the luciferase gene (Fig. R10, 
and section 4.3. of the Materials and Methods). 
 
Figure R10. Nucleotide sequence of the DNA fragments from the Ucp3 promoter that were used for 
luciferase reporter assays after H2O2 treatment. Nucleotide sequences (71 bp) containing the ARE (shown in 
blue) or the mutated ARE (mARE) with the substituted nucleotides shown in red. These sequences were cloned 
into the pGL4.27 vector, and each of the resulting plasmids (pGL4.27-ARE and pGL4.27-mARE) were used to 
transfect HL-1 cells.   
 
 
 
 
 
 
 
Figure R11. Luciferase reporter assay after H2O2-induced Nrf2 activation in HL-1 cells transfected with the 
plasmids pGL4.27-ARE or pGL4.27-mARE. Luciferase expression in HL-1 cells transfected with the pGL4.27 
plasmid containing the ARE (pGL4.27-ARE) or the mARE (pGL4.27-mARE) and treated with 300 μM H2O2 for 
6 h. Cells transfected with the empty pGL4.27 vector were used as a internal control. Histograms show the means 
± SEM of normalized firefly/Renilla luciferase expression from 7 independent experiments. C, control untreated 
cells. ***P < 0.001 with respect to control pGL4.27-ARE, ##P < 0.01 with respect to H2O2 pGL4.27-ARE. 
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As shown in Fig. R11, H2O2 treatment (300 μM for 6 h) increased luciferase expression 
around two-fold in cells transfected with the ARE but not in those transfected with the mARE. 
This result indicates that Nrf2 increases Ucp3 expression through its binding to the ARE region 
in the promoter of this gene. 
1.2.3. Nrf2 silencing prevents H2O2-induced UCP3 upregulation 
To further confirm that the increase in UCP3 expression under conditions of oxidative 
stress is mediated by Nrf2, we silenced Nrf2 expression using RNA interference (siNrf2) in 
HL-1 cells. Fig. R12A and B show that Nrf2 interference was effective, since Nrf2 mRNA and 
Nrf2 protein levels, as well as the mRNA expression of the Nrf2 target gene HO-1, were clearly 
reduced in H2O2-treated siNrf2 cells compared to control scrambled cells (Scr).  
A     B 
 
 
 
 
 
 
 
 
 
 
 
 
Figure R12. Effects of Nrf2 RNA interference on Nrf2, UCP3 and HO-1 expression after H2O2. (A) 
Representative immunoblot of Nrf2 and UCP3 protein levels in nuclear and mitochondrial extracts, respectively, 
from scrambled control (Scr) and Nrf2-interfered (siNrf2) HL-1 cells exposed to 300 μM H2O2 for 6 h. Lamin A-
C and porin were used as nuclear and mitochondrial protein loading controls, respectively. (B) Nrf2, HO-1 and Ucp3 
mRNA levels in Scr and siNrf2 HL-1 cells exposed to 300 μM H2O2 for 6 h. HPRT and β-actin were used as 
housekeeping genes for internal normalization. Histograms show the means ± SEM from 4 independent 
experiments. C, control untreated cells. *P < 0.05, **P < 0.01, with respect to Scr C; #P < 0.05, ##P < 0.01 with respect 
to Scr H2O2 group. 
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Importantly, the increase in Ucp3 mRNA and UCP3 protein expression induced by H2O2 
was not observed in siNrf2 cells (Fig. R12A and B). These results reinforce the conclusion from 
the above data, all of them indicating that the Nrf2 transcription factor is directly involved in 
H2O2-induced UCP3 upregulation. 
1.3. Physiological consequences of UCP3 upregulation induced by H2O2 
1.3.1. Upregulation of UCP3 via Nrf2 after H2O2 treatment increases cell survival 
Our previous experiments in which we analysed cell viability showed that the oxidative 
damage induced by 300 μM H2O2 treatment causes cell death in HL-1 cells after 
a 24 h exposure but not at shorter times (section 1.1.1. of the Results). In order 
to evaluate the possible protective role of Nrf2 and UCP3 against oxidative 
damage, we first analysed the effect of Nrf2 and Ucp3 silencing on the survival of 
cells exposed to oxidative damage. For this, we examined H2O2-treated HL-1 
cells by microscopy. As shown in Fig. R13, H2O2 exposure for 6 h did not 
produce any visible cell death in Scr control cells, in agreement with data in Fig. 
R3. However, both siNrf2 and siUCP3 cells exhibited increased cell death after 
6 h exposure to H2O2, which was more evident in siNrf2 cells (Fig. R13). 
 
 
 
 
 
 
 
Figure R13. Cell viability in Nrf2- and Ucp3-silenced cells after H2O2. Representative images of Scr, siNrf2 and 
siUCP3 HL-1 cells treated with 300 μM H2O2 for 6 h and untreated cells (control). Note the enhanced cell death 
in Nrf2- and UCP3-silenced cells compared with Scr cells after H2O2 treatment. 
 
These observations were confirmed by the determination of PI incorporation by flow 
cytometry in HL-1 cells, which was significantly higher in siNrf2 and siUCP3 cells after H2O2 
treatment than in Scr cells (Fig. R14). 
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Figure R14. Cell death in Nrf2- and Ucp3-silenced cells after H2O2. Cell death as determined by flow cytometry 
analysis of PI incorporation in Scr, siNrf2 and siUCP3 HL-1 cells exposed to 300 μM H2O2 for 6 h. Histograms 
show the means ± SEM of the percentage cell death induced by H2O2 treatment for 5 independent experiments. 
*P < 0.05 with respect to the Scr group. 
 
Moreover, comparable results were obtained by the estimation of apoptotic HL-1 cells by 
measuring cleaved caspase 3 expression levels, which clearly increased after a 6 h treatment 
with H2O2 in both siNrf2 and siUCP3 cells in comparison with control Scr cells (Fig. R15).  
 
 
 
 
Figure R15. Apoptotic cell death in Nrf2- and Ucp3-silenced cells after H2O2. Representative immunoblot of 
caspase 3 protein in cytosolic extracts from HL-1 cells exposed to 300 μM H2O2 for 6 h. Tubulin was used as 
protein loading control. C, control untreated cells. 
 
In addition, oxidative stress (as estimated by the DCF-DA fluorescence signal) was 
markedly higher in HL-1 cells subjected to Nrf2 or Ucp3 RNAi after H2O2 addition than in 
control cells (Fig. R16). Taken together, these findings indicate that both UCP3 and Nrf2 
promote cell survival under conditions of oxidative stress. 
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Figure R16. Oxidative stress in Nrf2- and Ucp3-silenced cells after H2O2. (A) Measurement of oxidative stress 
by flow cytometry as DCF-DA fluorescence in Scr, siNrf2 and siUCP3 HL-1 cells exposed to 300 μM H2O2 for 6 h 
or untreated cells (control). The percentages of positive cells are indicated. (B) Histograms represent the means 
± SEM of the ROS levels relative to the basal conditions for 6 independent experiments. C, control untreated cells. 
**P < 0.01, ***P < 0.001 with respect to Scr C, ##P < 0.01, ###P < 0.001 with respect to Scr H2O2 group. 
 
1.3.2. Effects of H2O2-induced UCP3 upregulation on cellular bioenergetics 
Next, to study the consequences of UCP3 induction under conditions of oxidative stress on 
cellular bioenergetics, we performed mitochondrial respiration experiments in HL-1 cells. To 
this end, we used a XF24 Extracellular Flux Analyser (Seahorse Bioscience). The effect of H2O2 
treatment for 3 h on respiration in siUCP3 and control Scr cells was determined under several 
conditions (Fig. R17A): (i) under basal conditions, (ii) after adding oligomycin to inhibit ATP 
synthesis, (iii) after adding the uncoupler FCCP to determine the maximal respiratory 
capacity, and (iv) after adding rotenone plus antimycin A to inhibit complexes I and III, 
respectively, and to determine non-mitochondrial respiration.  
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Figure R17. Effects of Ucp3 interference (siUCP3) on the oxygen consumption rate of HL-1 cells exposed to 
H2O2. (A) The oxygen consumption rate (OCR) was measured in scrambled control (Scr) and Ucp3-interfered 
(siUCP3) HL-1 cells exposed to 300 μM H2O2 for 3 h. Sequential additions are indicated with arrows: 5 µg/ml 
oligomycin (O), 300 nM FCCP (F), 1 µM rotenone plus 1 µM antimycin A (R+A). (B) Quantification of OCR in 
Scr and siUCP3 HL-1 cells exposed to 300 μM H2O2 for 3 h under basal conditions (basal) and after the addition 
of oligomycin (5 µg/ml; proton leak) and FCCP (300 nM; maximal respiration). Basal minus oligomycin values 
provides a measure of the OCR due to ATP turnover. FCCP minus basal values represents the reserve capacity. 
Non-mitochondrial respiration (rotenone plus antimycin A) was subtracted for each condition. Histograms show 
the means ± SEM from 10 independent experiments. C, control untreated cells. *P < 0.05, **P < 0.01 with respect 
to Scr C, #P < 0.05 with respect to Scr H2O2 group. 
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Fig. R17B shows that the H2O2 treatment significantly increased basal respiration in cells 
transfected with Scr siRNA compared to non-treated cells, although no similar increase was 
observed in siUCP3 cells. The addition of oligomycin allowed State 4 respiration to be assessed, 
an indicator of proton leak across the mitochondrial inner membrane. State 4 respiration 
increased in Scr cells after H2O2 treatment but not in siUCP3 cells (Fig. R17B). Hence, the 
increase in proton leak and basal respiration observed after H2O2 treatment can be partially 
attributed to UCP3 activation. These results indicate that UCP3 increases the proton 
conductance across the mitochondrial inner membrane after H2O2 treatment in HL-1 cells. 
Moreover, maximal respiration (FCCP), reserve capacity (FCCP−basal) or ATP turnover 
(basal−oligomycin) were not significantly modified by H2O2 either in Scr or in siUCP3 cells 
(Fig. R17B).  
The same protocol as in the previous experiment was applied to Nrf2-silenced cells (Fig. 
R18). The obtained results indicated that the effects of H2O2 on cellular bioenergetics observed 
in siUCP3 cells were reproduced after the interference of Nrf2 mRNA. Thus, in control Scr cells, 
basal respiration and proton leak increased after H2O2 treatment, while there was no effect on 
maximal respiration, reserve capacity or ATP turnover. On the contrary, the H2O2 effects on 
maximal respiration and proton leak were abolished in siNrf2 cells (Fig. R18B). Taken 
together, these results suggest that H2O2-induced UCP3 upregulation increases mitochondrial 
proton leak and, in turn, basal respiration. 
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Figure R18. Effects of Nrf2 interference (siNrf2) on the oxygen consumption rate of HL-1 cells exposed to 
H2O2. (A) The oxygen consumption rate (OCR) was measured in scrambled control (Scr) and Nrf2-interfered 
(siNrf2) HL-1 cells exposed to 300 μM H2O2 for 3 h. Sequential additions are indicated with arrows: 5 µg/ml, 
oligomycin (O), 300 nM FCCP (F), 1 µM rotenone plus 1 µM antimycin A (R+A). (B) Quantification of OCR in 
Scr and siNrf2 HL-1 cells exposed to 300 μM H2O2 for 3 h under basal conditions (basal) and after the addition of 
oligomycin (5 µg/ml; proton leak) and FCCP (300 nM; maximal respiration). Basal minus oligomycin values 
provides a measure of the OCR due to ATP turnover. FCCP minus basal values represents the reserve capacity. 
Non-mitochondrial respiration (rotenone plus antimycin A) was subtracted for each condition. Histograms show 
the means ± SEM from 10 independent experiments. C, control untreated cells. *P < 0.05, **P < 0.01 with respect 
to Scr C, #P < 0.05 with respect to Scr H2O2 group. 
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2. EFFECTS OF 4-HYDROXY-2-NONENAL (HNE) ON UCP3 
EXPRESSION AND FUNCTION  
2.1. Effects of HNE on UCP3 expression and Nrf2 nuclear accumulation 
The lipid peroxidation product 4-hydroxy-2-nonenal (HNE) is involved in the regulation 
of mitochondrial uncoupling (Echtay et al. 2005, Echtay et al. 2003, Parker et al. 2008a). In 
addition, HNE has been reported to induce the nuclear translocation of Nrf2 and to enhance 
the expression of its target genes in cardiomyocytes (Zhang et al. 2010). Following our finding 
that H2O2 upregulates UCP3 via Nrf2, we aimed to investigate whether HNE was also able to 
induce Nrf2-mediated UCP3 expression. 
2.1.1. HNE treatment does not induce cell death at low micromolar doses 
First, to establish the appropriate HNE dose to use in subsequent experiments, we 
estimated cell death in HL-1 cells exposed to three HNE concentrations, by analysing the 
incorporation of PI by flow cytometry. As shown in Fig. R19, the treatment with 20 or 60 µM 
HNE for 16 h did not significantly increase cell death, although a slight decrease in cell viability 
was detected at 60 µM. In contrast, a significant increase in cell death was observed at 100 µM 
(Fig. R19). We therefore concluded that 20 µM was a non-toxic appropriate dose to study 
HNE effects on UCP3 expression and Nrf2 nuclear accumulation in HL-1 cells, in accordance 
with reported data obtained in cardiomyocytes (Zhang et al. 2010).  
 
 
 
 
 
 
 
Figure R19. Dose-dependent cell death induced by HNE treatment. Flow cytometry analysis of PI 
incorporation by HL-1 cells treated with 20, 60, or 100 μM HNE for 16 h. Histograms show the mean ± SEM of cell 
survival from 4 independent experiments. C, control untreated cells. ***P < 0.001. 
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2.1.2. HNE treatment upregulates UCP3 expression 
We then analysed the expression levels of UCP3 after cellular exposure to HNE. Fig. R20 
shows that the treatment of HL-1 cells with 20 µM HNE for several hours significantly induced 
UCP3 expression. As seen in this figure, UCP3 protein levels were significantly increased from 
5 h of HNE treatment. 
 
 
 
 
Figure R20. Effects of HNE on UCP3 expression levels. Representative immunoblot of UCP3 protein levels in 
mitochondrial extracts from HL-1 cells exposed to 20 μM HNE at different exposure times. Porin levels were used 
as mitochondrial protein loading control. Histograms show the mean ± SEM from 10 independent experiments. 
C, control untreated cells. *P < 0.05, **P < 0.01. 
 
In addition, we analysed mRNA levels under the same conditions. Supporting the protein 
expression data, Ucp3 mRNA levels were also significantly increased by 20 µM HNE treatment 
at 3 and 6 h, whereas Ucp2 mRNA levels remained unaffected (Fig. R21). 
 
 
 
 
 
 
 
 
Figure R21. Effects of HNE on Ucp2 and Ucp3 mRNA levels. mRNA levels of Ucp2 and Ucp3, in HL-1 cells 
exposed to 20 μM HNE for 3 or 6 h. HPRT and β-actin were used as housekeeping genes for internal normalization. 
Histograms show the mean ± SEM from 5 independent experiments. C, control untreated cells. *P < 0.05, **P < 
0.01. 
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Next, we tested whether the increase in UCP3 expression was specifically due to the 
cellular stress conditions originated by the treatment with HNE. To answer this question, HL-
1 cells were pre-treated with the antioxidant N-acetylcysteine (NAC; 5 mM) for 1 h before the 
addition of HNE. Our data indicated that NAC partially abolished the UCP3 increase observed 
in response to HNE (Fig. R22). NAC modulates the intracellular thiol levels and increases the 
intracellular levels of glutathione (GSH) (Burgunder et al. 1989), supporting its synthesis when 
the demand for GSH is increased, as it occurs during an oxidative stress challenge. We 
conclude that the effects of HNE on UCP3 expression were mediated by enhanced oxidative 
stress. 
 
 
 
 
Figure R22. Effects of HNE on UCP3 expression levels. Representative immunoblot of UCP3 protein levels in 
mitochondrial extracts from HL-1 cells exposed to 20 µM HNE for 5 h with (+) or without (-) previous addition 
of 5 mM N-acetylcysteine (NAC) for 1 h. Porin was used as mitochondrial protein loading control. Histograms 
show the mean ± SEM from 5 independent experiments. C, control untreated cells. **P < 0.01 with respect to C, 
#P < 0.05 with respect to HNE group. 
 
2.1.3. HNE treatment induces nuclear accumulation of the transcription factor Nrf2 
Since H2O2 was able to induce Nrf2 nuclear accumulation (section 1.1.3.), we tested whether 
Nrf2 also accumulated in the nucleus after HNE treatment in HL-1 cells, as previously reported 
for mouse cardiomyocytes (Zhang et al. 2010). Nrf2 accumulation was observed in the nuclear 
fraction of HL-1 cells after 20 µM HNE treatment from 3 h (Fig. R23), an effect that occurred 
in parallel with increased UCP3 expression (Fig. R20).  
Moreover, there was also a significant increase in Nrf2 mRNA in cells treated with HNE for 
3 and 6 h, as well as in the mRNA of its target gene HO-1 (Fig. R24). 
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Figure R23. Effects of HNE on Nrf2 expression levels. Representative immunoblots of Nrf2 protein levels in 
nuclear extracts from HL-1 cells exposed to 20 μM HNE at different exposure times. Hsp90 levels were used as 
protein loading control. Histograms show the mean ± SEM from 10 independent experiments. C, control 
untreated cells. *P < 0.05, **P < 0.01, ***P < 0.001. 
 
 
 
 
 
 
 
 
 
 
Figure R24. Effects of HNE on Nrf2 and HO-1 mRNA levels. mRNA levels of Nrf2 and HO-1 in HL-1 cells 
exposed to 20 μM HNE for 3 or 6 h. HPRT and β-actin were used as housekeeping genes for internal normalization. 
Histograms show the mean ± SEM from 5 independent experiments. C, control untreated cells. **P < 0.01, ***P < 
0.001. 
 
In addition, we showed that HNE-induced nuclear accumulation of Nrf2 was prevented by 
a pre-treatment with NAC (Fig. R25). Therefore, these results indicate that Nrf2 accumulates 
in the nucleus of HL-1 cells as a consequence of the cellular stress conditions generated by HNE 
treatment. 
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Figure R25. Effects of HNE on Nrf2 expression levels. Representative immunoblot of Nrf2 protein levels in 
nuclear extracts from HL-1 cells exposed to 20 µM HNE for 5 h with (+) or without (-) previous addition of 5 mM 
N-acetylcysteine (NAC) for 1 h. Hsp90 levels were used as protein loading control. Histograms show the mean ± 
SEM from 5 independent experiments. C, control untreated cells. ***P < 0.001 with respect to C, #P < 0.05 with 
respect to HNE group. 
 
2.2. Involvement of Nrf2 in HNE-induced UCP3 upregulation 
2.2.1. Nrf2 binds to the Ucp3 promoter after HNE treatment  
Given that the treatment with HNE induces both UCP3 upregulation and Nrf2 nuclear 
accumulation in HL-1 cells, we wondered whether Nrf2 could induce UCP3 expression in 
response to HNE, similar to what we found when the cells were exposed to H2O2 (section 1.2.). 
To study the possible binding of Nrf2 to the ARE conserved region of the Ucp3 promoter (Fig. 
R8), we performed ChIP analysis following the treatment of HL-1 cells with 5, 10 or 20 µM 
HNE for 3 or 6 h. As shown in Fig. R26, the results indicated that Nrf2 binds to the ARE region 
of the Ucp3 promoter in HL-1 cells after 3 h exposure to 5, 10 or 20 µM HNE. 
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Figure R26. ChIP assay of Nrf2 binding to the Ucp3 promoter after HNE treatment. ChIP assay 
of Nrf2 binding to the mouse Ucp3 promoter in HL-1 cells exposed to 5, 10 and 20 μM HNE for 3 or 6 h. RT-PCR 
quantification and enrichment of positive and negative regions after immunoprecipitation with Nrf2 or control 
IgG antibodies are shown. Histograms show the means ± SEM from 3 independent experiments. C, control 
untreated cells. *P < 0.05, **P < 0.01. 
 
2.2.2. HNE-induced UCP3 upregulation is mediated by Nrf2 
Once we showed that Nrf2 binds to the Ucp3 promoter at its conserved ARE region after 
HNE treatment, it was necessary to examine whether this binding promotes the transcription 
of the gene. To achieve this, we carried out luciferase reporter assays that were conducted in 
HL-1 cells. These cells were transfected with a plasmid (pGL4.27) containing a 71 bp that 
included either the ARE or a mutated ARE (mARE) upstream of the luciferase gene (Fig. R10 
and section 4.3. of the Materials and Methods,).  
HNE treatment (20 µM for 5 h) induced Nrf2 nuclear accumulation, which significantly 
increased luciferase expression in cells transfected with the ARE but not in those transfected 
with the mARE (Fig. R27A). 
We also performed luciferase reporter experiments in HL-1 cells using another plasmid that 
contained a much longer fragment of the Ucp3 promoter, also including either the wild-type 
ARE region (pGL4.27-Prom) or a mutated ARE version (pGL4.27-mProm). This DNA 
fragment containing the promoter region of Ucp3 was 2205 bp (from -2145 to +60 positions 
relative to the transcription start site). The data in Fig. R27B show that there was an increased 
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luciferase expression in cells transfected with the promoter region containing the original 
ARE, but not in those transfected with the promoter region containing the mutated ARE. 
Therefore, we conclude that the ARE region is essential for the upregulated transcription of 
the Ucp3 gene after HNE treatment. 
A 
 
 
 
 
 
B 
 
 
 
 
 
 
 
Figure R27. Luciferase reporter assay after HNE-induced Nrf2 activation in HL-1 cells transfected with the 
ARE-containing Ucp3 promoter region. Luciferase expression in HL-1 cells transfected with the pGL4.27 
plasmid including (A) the 71 bp ARE-containing Ucp3 promoter region (pGL4.27-ARE) or the mutated ARE 
(pGL4.27-mARE) and (B) the 2205 bp ARE-containing Ucp3 promoter region that included the ARE (pGL4.27-
Prom) or the mutated ARE (pGL4.27-mProm) and treated with 20 μM HNE for 6 h. Cells transfected with the 
empty pGL4.27 vector were used as internal control. Histograms show the means ± SEM of normalized 
firefly/Renilla luciferase expression (n = 12 for the 71 bp region, and n = 7 for the 2205 bp region). C, control 
untreated cells. **P < 0.01 with respect to control pGL4.27-ARE, ##P < 0.01 with respect to HNE pGL4.27-ARE. 
***P < 0.001 with respect to control pGL4.27-Prom, #P < 0.05 with respect to HNE pGL4.27-Prom. 
 
2.2.3. Nrf2 silencing prevents HNE-induced UCP3 upregulation 
To confirm that the increase in UCP3 expression after HNE treatment is mediated by Nrf2, 
we silenced Nrf2 mRNA using RNA interference (siNrf2) in HL-1 cells and analysed the levels 
of UCP3 and Ucp3 mRNA (Fig. R28). As seen in this figure, after silencing Nrf2, both the 
expression of Nrf2 (Fig. R28A) and Nrf2 mRNA (Fig. R28B), as well as the mRNA of its target 
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gene HO-1 (Fig. R28B), were clearly reduced when treated with HNE, in comparison with 
treated cells previously transfected with Scr RNAi (Fig. R28A and B). Therefore, the silencing 
of Nrf2 was efficient. With respect to UCP3, our results show that this protein is not induced 
in response to HNE treatment when Nrf2 is silenced (Fig. R28A).  
A               B 
 
 
 
 
 
 
 
 
 
Figure R28. Effects of Nrf2 RNA interference on UCP3, Nrf2 and HO-1 expression after HNE treatment. 
(A) Representative immunoblots of Nrf2 and UCP3 protein levels in nuclear and mitochondrial extracts, 
respectively, from scrambled control (Scr) and Nrf2-interfered (siNrf2) HL-1 cells exposed to 20 μM HNE for 6 h. 
Lamin A-C and porin were used as nuclear and mitochondrial protein loading controls, respectively. Numbers 
indicate different HNE-treated samples. (B) Nrf2, HO-1 and Ucp3 mRNA levels in Scr and siNrf2 HL-1 cells exposed 
to 20 μM HNE for 6 h. HPRT and β-actin were used as housekeeping genes for internal normalization. Histograms 
show the means ± SEM from 6 independent experiments. C, control untreated cells. *P < 0.05, ***P < 0.001 with 
respect to Scr C; #P < 0.05, ### P < 0.001 with respect to Scr HNE group.  
 
Furthermore, the expression of the Ucp3 gene is not enhanced in siNrf2 cells treated with 
HNE, as indicated by the absence of increased levels of Ucp3 mRNA when compared with 
control Scr cells (Fig. R28B). These results are consistent with the data shown above and 
indicate that Nrf2 is involved in HNE-induced UCP3 upregulation. 
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2.3. Physiological consequences of UCP3 upregulation induced by HNE 
2.3.1. Upregulation of UCP3 via Nrf2 after HNE treatment increases cell survival 
We next examined whether the Nrf2-dependent regulation of UCP3 was important for cell 
viability under conditions of HNE exposure. As shown in Fig. 19, the treatment with 100 µM 
HNE for 16 h causes cell death in HL-1 cells, but not the exposure to 20 µM HNE. In agreement 
with this data, Scr HL-1 cells treated with 20 µM HNE for 5 or 16 h did not show any 
indications of cell death when examined by microscopy (Fig. R29A and B, left panels).  
A      B   
 
 
 
 
 
 
 
 
 
C 
 
 
 
 
 
Figure R29. Cell viability in Nrf2- and Ucp3-silenced cells after HNE treatment. (A, B) Representative images 
of Scr, siNrf2 and siUCP3 HL-1 cells treated with 20 μM HNE for (A) 5 h and (B) 16 h, or untreated cells (control). 
Cell death was detected as PI incorporation (red nuclei), and viable cells as calcein incorporation (green 
cytoplasms). Double positive (PI+Calc+) were counted as dead cells. Note the enhanced cell death in Nrf2- and 
UCP3- silenced cells compared with Scr cells after 16 h HNE treatment. (C) Histograms show the means ± SEM 
from 3 independent experiments. *P < 0.05 relative to each correspondent control. C, control untreated cells. #P < 
0.05, ###P < 0.001 relative to Scr HNE.  
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On the contrary, we observed that both siNrf2 and siUCP3 cells exhibited signs of cell death 
after exposure to the same dose of HNE at 5 h (Fig. R29A) and even clearer signs at 16 h (Fig. 
R29B). 
These observations were confirmed by microscopy examination of PI incorporation, which 
allows the detection of dead cells (red nuclei), and calcein incorporation, which allows the 
detection of viable cells (green cytoplasm). The ratio dead/total cells was significantly higher 
in siNrf2 and siUCP3 cells after 20 µM HNE treatment than in control cells (Fig. R29C), and 
the effects on cell death were more evident after 16 h. These results indicate that both UCP3 
and Nrf2 promote cell survival upon the challenge of HNE treatment. 
2.3.2. Effects of HNE-induced UCP3 upregulation on cellular bioenergetics  
Previous reports have shown that HNE activates UCP3-mediated proton conductante 
(Aguirre and Cadenas 2010, Echtay et al. 2005, Echtay et al. 2003, Parker et al. 2008a). To study 
the consequences of HNE-induced UCP3 upregulation on cellular bioenergetics, we performed 
mitochondrial respiration experiments in HL-1 cells, using the XF24 Extracellular Flux 
Analyser (Seahorse Bioscience). HL-1 cells were silenced for Ucp3 by RNA interference 
(siUCP3), and the effect of HNE treatment on the oxygen consumption rate (OCR) in siUCP3 
and control Scr cells was determined as described in section 1.3.2. Thus, we initially measured 
OCR under basal conditions, subsequently after adding oligomycin, then after adding the 
uncoupler FCCP, and finally, after adding rotenone plus antimycin A (Fig. R30A). 
Our results indicated that HNE significantly increased basal respiration in cells transfected 
with both Scr RNAi and siUCP3. State 4 respiration was assessed by adding oligomycin to the 
cells, in order to show the leakage of protons across the IMM. Fig. R30B shows that there was 
a four-fold increase in proton leak in Scr cells after HNE treatment, but this increase was less 
than two-fold in siUCP3 cells. Notably, maximal respiration (FCCP) was significantly reduced 
after HNE treatment, both in siUCP3 and in Scr control cells (Fig. R30B). As a result, the 
reserve capacity (FCCP−basal) was therefore inexistent in HNE-treated cells. Likewise, ATP 
turnover (basal−oligomycin) was increased after HNE treatment either in Scr or in siUCP3 
cells (Fig. R30B). 
Taken together, these results suggest that the much higher basal respiration observed in 
cells after HNE treatment might be due to both increased proton leak and ATP turnover. The 
increased proton leak could be partially attributed to UCP3 activation, confirming previous 
reports showing that UCP3 increases the proton conductance across the mitochondrial inner 
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membrane when activated by HNE (Aguirre and Cadenas 2010, Echtay et al. 2005, Echtay et 
al. 2003, Parker et al. 2008a). 
A 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
Figure R30. Effects of Ucp3 interference (siUCP3) on the oxygen consumption rate of HL-1 cells exposed 
to HNE. (A) The oxygen consumption rate (OCR) was measured in scrambled control (Scr) and Ucp3-interfered 
(siUCP3) HL-1 cells exposed to 20 μM HNE for 5 h. Sequential additions are indicated with arrows: 5 μg/ml 
oligomycin (O), 300 nM FCCP (F), 1 µM rotenone plus 1 µM antimycin A (R+A). (B) Quantification of OCR in 
Scr and siUCP3 HL-1 cells exposed to 20 μM HNE for 5 h under basal conditions (basal) and after the addition of 
oligomycin (5 µg/ml; proton leak) and FCCP (300 nM; maximal respiration). Basal minus oligomycin values 
provides a measure of the OCR due to ATP turnover. FCCP minus basal values represent the reserve capacity. 
Non-mitochondrial respiration (rotenone plus antimycin A) was subtracted for each condition. Histograms show 
the means ± SEM from 5 independent experiments. C, control untreated cells. *P < 0.05, **P < 0.01, ***P < 0.001 
with respect to Scr C; #P < 0.05, ##P < 0.01 with respect to Scr HNE group. 
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PART II. ANALYSIS OF THE CARDIOPROTECTIVE ROLE OF UCP3 
AGAINST ISCHEMIA-REPERFUSION INJURY: INVOLVEMENT OF THE 
TRANSCRIPTION FACTOR NRF2 
1. STUDY OF NRF2-MEDIATED UCP3 INDUCTION AND ITS 
CARDIOPROTECTIVE ROLE IN THE ISOLATED MOUSE HEART 
AFTER ISCHEMIA-REPERFUSION 
1.1. Ischemia-reperfusion (IR) increases UCP3 expression and Nrf2 nuclear 
accumulation in the isolated mouse heart 
To investigate whether the Nrf2-mediated UCP3 induction that we described in cells 
subjected to H2O2 or HNE treatment could have pathophysiological relevance, we studied 
isolated mouse hearts subjected to ischemia-reperfusion (IR), a condition known to increase 
ROS production and oxidative damage (Zweier and Talukder 2006). For this, we started by 
analysing UCP3 expression and Nrf2 nuclear accumulation in this multicellular system (Fig. 
R31). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure R31. UCP3 and Nrf2 expression levels in mouse heart after ischemia (I) and ischemia-reperfusion 
(IR). Representative immunoblot of UCP3 in total extracts and Nrf2 in nuclear extracts from control (C) hearts, 
and hearts subjected to ischemia (I) or ischemia-reperfusion (IR). Numbers 1-8 indicate different mice. Tubulin 
and Hsp90 were used as protein loading controls in total and nuclear fractions, respectively. Histograms show 
the means ± SEM relative to control from 4 hearts per group. *P < 0.05.  
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Hearts were perfused ex vivo using the Langendorff perfusion system to apply protocols of 
ischemia (I) and IR (Fig. M6 and section 8.2. of the Materials and Methods). They were 
allowed to stabilize for 20 min before the flow was completely stopped to generate global 
normothermic ischemia for 40 min. The flow was then restored, and the hearts were reperfused 
for 60 min. In agreement with the results we obtained in cells, Nrf2 and UCP3 expression levels 
increased significantly after IR in the nuclear and total tissue extracts, respectively (Fig. R31), 
suggesting that Nrf2-mediated UCP3 upregulation might also take place during cardiac IR. 
1.2. Infarct size after IR increases in hearts from UCP3-KO compared to WT mice: 
cardioprotective role of UCP3 against IR injury 
Since UCP3 has been reported to decrease ROS production and oxidative damage (Brand 
and Esteves 2005, Mailloux and Harper 2011, Toime and Brand 2010), and given that this 
protein is upregulated via Nrf2 in response to oxidative stress (sections 1.2. and 2.2. of the 
Results, Part I) to promote cell survival (sections 1.3.1. and 2.3.1. of the Results, Part I), we 
hypothesized that UCP3 could play a protective role against IR damage in the heart.  
To test this hypothesis, we investigated whether hearts lacking UCP3 have increased tissue 
damage after an ischemic insult compared to wild-type hearts. For this, hearts from UCP3-
knockout (UCP3-KO) and wild-type (WT) mice were subjected to IR using the Langendorff 
system (Fig. R32).  
 
 
Figure R32. Infarct size in hearts from WT and UCP3-KO mice subjected to IR. Representative images of 
heart slices from WT and UCP3-KO mice subjected to IR and stained with tetrazolium chloride (TTC), which 
results in white necrotic tissue and red viable tissue. Histograms show the means ± SEM of the percentage of 
infarct as necrotic area related to risk area (total) (n = 7-8 hearts per group). *P < 0.05. 
 
After 20 min stabilization, the flow was completely stopped to generate global 
normothermic ischemia for 40 min, and then restored for 60 min. At the end of the IR protocol, 
the hearts were stained with tetrazolium chloride (TTC), and the infarct size was analysed to 
determine tissue damage (necrosis) (section 8.4. of the Materials and Methods). The analysis 
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of the percentage of the necrotic area (white) in relation to the risk area (total), showed a 
significantly larger infarction after IR in hearts from UCP3-KO (64.1%) mice compared to WT 
(53.5%) (Fig. R32), suggesting that UCP3 plays a cardioprotective role against IR injury.  
1.3. Creatine kinase release after IR is higher in hearts from UCP3-KO mice than in 
those from WT mice 
Creatine kinase (CK) levels are elevated when myocardial cellular damage occurs (Blanke 
et al. 1984, Ellis 1991). Hence, CK activity is normally used in the diagnosis of myocardial 
infarction as a biomarker to assess damage. To determine IR injury in the hearts from UCP3-
KO and WT mice, we measured CK activity levels in the coronary effluent during the perfusion 
experiments.  
 
Figure R33. Creatine kinase release during reperfusion of hearts from WT and UCP3-KO mice. Enzymatic 
units of creatine kinase (CK) measured in the coronary effluent over time during the reperfusion of WT and 
UCP3-KO hearts. Histograms show the means ± SEM of the area under the curve (AUC) (n = 6-8 hearts per group) 
*P < 0.05.  
 
Thus, after 20 min stabilization, the hearts were subjected to global normothermic ischemia 
for 40 min, and then to reperfusion for 60 min. Afterwards we analysed total units of CK 
released in the coronary effluent throughout the experiment, and compared the results 
obtained in WT and UCP3-KO hearts (Fig. R33). Our results showed that hearts lacking UCP3 
presented a significant increment in the total CK release after IR compared to WT hearts, 
thereby indicating that UCP3-KO hearts suffer more damage than WT hearts (Fig. R33). CK 
enzymatic units are represented over time throughout the experiment, usually showing a peak 
30 min after ischemia (Fig. R33). This is later than expected due to the delayed release of 
effluent caused by the perfusion chamber dead volume (see section 8.5 of the Materials and 
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Methods). The peak reflects the highest CK levels, which are being released at the beginning 
of reperfusion, precisely during a time period between 10 and 20 min into reperfusion. 
We also analysed whether there was a basal damage in the UCP3-KO hearts. For this, we 
measured the CK pre-ischemic units. As shown in Fig. R34, the results obtained proved that 
the basal damage, as determined by CK activity, was not significantly different in UCP3-KO 
and WT hearts.  
 
 
 
 
 
 
Figure R34. Creatine kinase basal levels of hearts from WT and UCP3-KO mice. Enzymatic units of creatine 
kinase (CK) measured in the coronary effluent after stabilization and before ischemia in WT and UCP3-KO 
hearts. Histograms show the means ± SEM of enzymatic units (n = 6-8 hearts per group). 
 
Taken together, these results indicate that the hearts that express UCP3 are significantly 
less damaged than the UCP3-KO hearts after IR, despite similar levels of damage occurring in 
basal conditions. Therefore, we conclude that UCP3 positively influences the outcome of an 
ischemic insult followed by reperfusion. 
1.4. Infarct size after IR increases in hearts from Nrf2-KO compared to WT mice: 
cardioprotective role of Nrf2 against IR injury 
Our data above show that UCP3 is upregulated in parallel with Nrf2 nuclear accumulation 
in the heart after IR, and that UCP3 provides cardioprotection against IR damage. Moreover, 
we found that UCP3 is induced via Nrf2 in cells (sections 1.2. and 2.2. of the Results, Part I) to 
confer protection against oxidative stress (sections 1.3.1. and 2.3.1. of the Results, Part I). 
Therefore, we wondered whether Nrf2 could also have a protective role against IR injury. To 
test this possibility, we analysed the infarct size of hearts from Nrf2-KO mice subjected to IR, 
using the Langendorff system (Fig. R35). Thus, the hearts were allowed to stabilize for 20 min, 
and then subjected to 40 min global normothermic ischemia followed by 60 min reperfusion. 
At the end of the IR protocol, the hearts were stained with TTC, and the infarct size was 
determined to observe tissue damage (section 8.4. of the Materials and Methods). The 
 
 
100 
 
 RESULTS 
percentage of the necrotic area (white) in relation to the risk area (total) showed a significantly 
larger infarction in hearts from Nrf2-KO mice compared to WT mice (Fig. R35). Importantly, 
the percentage of infarct size in Nrf2-KO hearts was very similar to that of the UCP3-KO hearts 
(63.3% and 64.1%, respectively, compared to 53.5% of WT hearts), strongly suggesting that, 
like UCP3, Nrf2 plays a cardioprotective role against IR injury. 
 
 
Figure R35. Infarct size in hearts from WT and Nrf2-KO mice subjected to IR. Representative images of heart 
slices from WT and Nrf2-KO mice subjected to IR and stained with tetrazolium chloride (TTC), which results 
in white necrotic tissue and red viable tissue. (B) Histograms show the means ± SEM of the percentage of infarct 
as necrotic area related to risk area (total) (n = 5-7 hearts per group). *P < 0.05. 
 
1.5. Creatine kinase release after IR is higher in hearts from Nrf2-KO mice than in those 
from WT mice 
As we did for UCP3-KO mice, we also determined CK levels in the coronary effluent of Nrf2-
KO mice during the perfusion experiments, which allows an estimation of IR damage (Fig. 
R36). For this, after 20 min stabilization, the hearts were subjected to global normothermic 
ischemia for 40 min, and then to reperfusion for 60 min. We then analysed total units of CK 
released in the coronary effluent throughout the IR experiment, and compared the results 
between the WT and the Nrf2-KO hearts. As shown in Fig. R36, the hearts lacking Nrf2 
exhibited a significant increment in the total CK release after IR compared to the WT hearts, 
indicating that Nrf2-KO hearts suffer more damage after IR, and therefore suggesting that Nrf2 
plays a cardioprotective role against IR injury. The increase in cardiac damage shown by Nrf2-
KO hearts after IR injury compared to WT hearts indicates that those are less protected and 
therefore more vulnerable to IR damage, a result similar to that found in UCP3-KO mice.  
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The CK released during reperfusion in Nrf2-KO mice, measured as the area under the curve, 
was very similar to that in UCP3-KO hearts (331 and 316 AUC, respectively, compared to 221 
AUC in WT hearts) (section 1.3.). 
 
Figure R36. Creatine kinase release during reperfusion of hearts from WT and Nrf2-KO mice. Enzymatic 
units of creatine kinase (CK) measured in the coronary effluent over time during the reperfusion of WT and Nrf2-
KO hearts. Histograms show the means ± SEM of the area under the curve (AUC) (n = 4-6 hearts per group). *P < 
0.05. 
 
Interestingly, we found that, in contrast to UCP3-KO hearts (Fig. R34), there was a basal 
damage in the Nrf2-KO hearts, as indicated by the elevated pre-ischemic CK units, which were 
two-fold higher than in the WT hearts (Fig. R37).  
 
 
 
 
 
 
 
 
Figure R37. Creatine kinase basal levels of hearts from WT and Nrf2-KO mice. Enzymatic units of creatine 
kinase (CK) measured in the coronary effluent after stabilization and before ischemia in WT and Nrf2-KO hearts. 
Histograms show the means ± SEM of enzymatic units (n = 4-6 hearts per group).  
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2. STUDY OF THE INVOLVEMENT OF NRF2-MEDIATED UCP3 
INDUCTION IN ISCHEMIC PRECONDITIONING IN THE 
ISOLATED MOUSE HEART 
2.1. Cardiac ischemic preconditioning (IPC) increases UCP3 expression levels and Nrf2 
nuclear accumulation 
The results shown above, together with those obtained in cells (Part I of the Results), 
suggest that Nrf2-mediated UCP3 induction could be involved in protecting the heart against 
the damaging effects of IR. Ischemic preconditioning (IPC) is an endogenous adaptive 
mechanism that consists of a series of repetitive short periods of sub-lethal myocardial 
ischemia followed by reperfusion which protects the heart from a subsequent prolonged 
ischemic insult (Yellon and Downey 2003). As ROS may be one of the several triggers proposed 
for IPC (Cai et al. 2008, Halestrap et al. 2007, Murphy and Steenbergen 2008) we studied 
whether Nrf2-mediated UCP3 induction could be involved in this phenomenon. 
We first examined the effects of IPC on UCP3 expression. Hearts were perfused using the 
Langendorff perfusion system. We applied a protocol for IPC, consisting of 2 cycles of 5 min 
ischemia plus 5 min reperfusion, before IR (40 min global normothermic ischemia followed by 
60 min reperfusion), and then evaluated UCP3 protein expression levels in total extracts. As 
shown in Fig. R38, we found that UCP3 was upregulated in hearts subjected to IPC, even to a 
higher extent than after IR, which strongly suggests the involvement of UCP3 in IPC. 
 
 
 
 
 
 
Figure R38. UCP3 expression levels in mouse hearts after I, IR or ischemic preconditioning (IPC). 
Representative immunoblot of UCP3 in total extracts from control (C) hearts and hearts subjected to I, IR, or 
IPC prior to IR (IPC+IR). Numbers 1-8 indicate different mice. Tubulin was used as protein loading control. 
Histograms show the means ± SEM relative to control from 4 hearts per group. *P < 0.05, **P < 0.01. 
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To determine the precise moment at which UCP3 induction occurred, we examined UCP3 
expression levels after IPC+C, IPC+I and IPC+IR (Fig. R39). The increase in UCP3 expression 
induced by IPC was only observed when the IPC protocol was applied before an injury-
inducing IR event, but not when the IPC was followed solely by normal perfusion or by 
ischemia (Fig. R39). This indicates that IPC alone is not sufficient to upregulate UCP3, but a 
damaging IR event following IPC is necessary for UCP3 upregulation. 
 
 
 
 
 
Figure R39. Effects of IPC on UCP3 expression levels in mouse hearts subjected to I or IR. Representative 
immunoblot of UCP3 in total extracts from control (C), I and IR hearts subjected (+) or not (-) to IPC. Tubulin 
was used as protein loading control. Histograms show the means ± SEM relative to control from 4 hearts per 
group. *P < 0.05, **P < 0.01 with respect to C; #P = 0.062 with respect to IR(-). 
 
We next analysed the Nrf2 levels in the nuclear extracts of the myocardial tissue after the 
same IPC perfusion protocols described above. Our results indicated that Nrf2 significantly 
accumulated in IPC+IR hearts, even to a higher degree than in IR hearts (Fig. R40). 
Interestingly, Nrf2 accumulated in the nucleus in parallel with increased mitochondrial UCP3 
expression (Fig. R38). 
 
 
 
 
Figure R40. Nrf2 expression levels in mouse hearts after I, IR or IPC. Representative immunoblot of Nrf2 in 
nuclear extracts from control (C) hearts and hearts subjected to I, IR or IPC prior to IR (IPC+IR). Numbers 1-8 
indicate different mice. Hsp90 was used as protein loading control. Histograms show the means ± SEM relative 
to control from 4 hearts per group. *P < 0.05, ***P < 0.001. 
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As in the case of UCP3 regulation (Fig. R39), the nuclear accumulation in Nrf2 induced by 
IPC occurred only when the IPC protocol was applied before an injury-inducing IR event, but 
not when the IPC was followed solely by normal perfusion or by ischemia (Fig. R41). This 
result indicates that, as for UCP3 expression, IPC alone is not sufficient to increase Nrf2 
expression, but a prolonged IR event following IPC is necessary for Nrf2 induction.   
 
 
 
 
 
Figure R41. Effects of IPC on Nrf2 expression levels in mouse hearts subjected to I or IR. Representative 
immunoblot of Nrf2 in nuclear extracts from control (C), I and IR hearts subjected (+) or not (-) to IPC. Hsp90 
was used as protein loading control. Histograms show the means ± SEM relative to control from 4 hearts per 
group. *P < 0.05, ***P < 0.001 with respect to C; ##P < 0.01 with respect to IR (-). 
 
Taken together, these results suggest that the Nrf2-mediated induction of UCP3, which we 
showed in cells treated with H2O2 or HNE, could be conferring protection to the heart under 
oxidative stress induced by IR, and that this event might also be involved in IPC. 
2.2. IPC does not reduce infarct size after IR in hearts from UCP3-KO mice: 
involvement of UCP3 in IPC 
Next, to study whether UCP3 is involved in the protective mechanism of IPC as suggested 
by the data above, we determined the infarct size in hearts obtained from preconditioned 
UCP3-KO and WT mice.  
For these experiments, an IPC protocol (2 cycles of 5 min ischemia plus 5 min reperfusion) 
was performed before IR (40 min global normothermic ischemia followed by 60 min 
reperfusion) to determine whether cardiac tissue damage would be reduced in UCP3-KO 
hearts, as reported for wild-type hearts (Murry et al. 1986). Our results showed that, as 
expected, preconditioned hearts from WT mice exhibited a significantly reduced infarct size 
after IR compared to non-preconditioned WT hearts (Fig. R42). By contrast, the hearts from 
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UCP3-KO mice subjected to IPC exhibited no differences in infarct size after IR compared to 
the hearts from UCP3-KO mice subjected to IR only (Fig. R42), thus showing that the IPC 
protocol was not effective in mice lacking UCP3. Moreover, the infarct size after IR in UCP3-
KO mice was larger than in WT mice, both in the presence and absence of IPC (Fig. R42). On 
the whole, these results indicate a clear implication of UCP3 in the IPC phenomenon and its 
protective effect against IR injury. 
 
 
 
 
 
 
 
Figure R42. Infarct size in hearts from WT and UCP3-KO mice subjected to IR and IPC. Representative 
images of heart slices from WT and UCP3-KO mice subjected to IR, or IPC prior to IR (IPC+IR) and stained with 
tetrazolium chloride (TTC), which results in white necrotic tissue and red viable tissue. Histograms show the 
means ± SEM of the percentage of infarct as necrotic area (white) related to risk area (total) (n = 6-8 hearts per 
group). *P < 0.05 with respect to WT IR; #P < 0.05 with respect to UCP3-KO IR group. 
 
2.3. Creatine kinase release after IR is higher in preconditioned hearts from UCP3-KO 
mice than in those from WT mice 
As in the IR experiments (section 1.3.), we also analysed CK enzymatic units released in the 
coronary effluent throughout the IPC+IR experiment, and compared the results between WT 
and UCP3-KO hearts. UCP3-KO hearts displayed increased CK release with respect to WT 
hearts after IPC+IR (324 to 218 AUC, respectively) (Fig. R43), which confirmed that IR caused 
more damage to UCP3-KO than to WT hearts, even after IPC. 
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Figure R43. Effects of IPC on creatine kinase release during reperfusion of hearts from WT and UCP3-KO 
mice. Enzymatic units of creatine kinase (CK) measured in the coronary effluent over time during reperfusion of 
WT and UCP3-KO mice subjected (+) or not (-) to IPC. Histograms show the means ± SEM of the area under the 
curve (AUC) (n = 6 mice per group). *P < 0.05. 
 
Regarding the analysis of CK release, the comparison between preconditioned and non-
preconditioned hearts subjected to IR cannot be performed due to a methodological problem. 
The IPC+IR protocols are 20 min longer than the IR experiments (Fig. M6 and section 8.2. of 
the Materials and Methods). During these 20 min, there are two 5-min periods of reperfusion 
releasing effluent that are absent in IR protocols and make the comparison meaningless. 
Therefore, we grouped only comparable experiments, and thus Fig. R43 shows the results of 
CK activity levels of IPC+IR perfused hearts from WT and UCP3-KO mice. 
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Mitochondria are a major source of ROS in cells, and mitochondrial superoxide (O2·−) 
production is highly sensitive to the protonmotive force (Δp) created across the IMM by the 
electron transport chain (ETC) (Korshunov et al. 1997). The activation of uncoupling proteins 
(UCPs) and the subsequent mitochondrial depolarization have been proposed as a mechanism 
to decrease mitochondrial O2·− generation (Brand and Esteves 2005, Mailloux and Harper 2011, 
Negre-Salvayre et al. 1997). This hypothesis, however, remains controversial (Nabben et al. 
2011, Shabalina and Nedergaard 2011). It has been demonstrated that UCPs can be activated by 
endogenous (Talbot et al. 2003) and exogenous (Echtay et al. 2002) O2·−, as well as by lipid 
peroxidation products such as 4-hydroxy-2-nonenal (HNE) (Aguirre and Cadenas 2010, 
Murphy et al. 2003, Parker et al. 2008a), suggesting that UCPs are central to the mitochondrial 
response to ROS. It is unclear, however, whether UCP expression is regulated by oxidative 
stress and, if this is the case, what are the physiological consequences of such regulation.  
1. UCP3 EXPRESSION INCREASES IN RESPONSE TO OXIDATIVE 
STRESS, AN EFFECT MEDIATED BY THE TRANSCRIPTION 
FACTOR NRF2 
The results described in this thesis show that the treatment with sub-toxic concentrations 
of the oxidant H2O2 or the lipid electrophile HNE, induces the upregulation of UCP3 in both 
C2C12 and HL-1 mouse cell lines. We used doses of these compounds that cause cellular stress 
but not cell death. H2O2 is relatively unreactive compared to O2·− but, in the presence of ferrous 
iron (Fe2+), it can induce the generation of highly reactive hydroxyl radicals (OH·) via the 
Fenton reaction. Then, OH· can initiate lipid peroxidation cascades in phospholipid 
membranes. Moreover, the products of sugar, protein, and lipid oxidation can cause secondary 
damage to proteins, which may lose their catalytic function and undergo selective degradation. 
One of the most abundant lipid peroxidation products, HNE, has been described as an 
activator of UCPs, and it has been proposed that the activation of UCPs by HNE would induce 
mild uncoupling, therefore decreasing IMM potential and subsequently superoxide generation 
by the ETC (Echtay et al. 2003). Thus, HNE would act as a biological signal to decrease 
mitochondrial ROS production.  
The effects of H2O2 and HNE on protein induction are specific for UCP3, as the expression 
of UCP2, the other UCP present in skeletal muscle and heart, is not affected by these 
treatments. UCP3 upregulation occurs after short exposure times (3-5 h) to these stressors, 
which is compatible with the exceptionally short half-life of UCP3 (0.5–4 h) compared to that 
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of other mitochondrial proteins such as ANT or UCP1, which have longer half-lives (Azzu et 
al. 2010a, Azzu et al. 2010b). The degradation of UCP3 occurs through ubiquitylation via 26S 
proteasome and requires a specific mitochondrial status consisting of high matrix ATP 
concentration and a high ΔΨm (Mookerjee and Brand 2011). This rapid turnover has been 
suggested to represent a means of dynamically regulating this protein in various physiological 
contexts including the adaptation to fasting and protection from oxidative damage (Azzu et 
al. 2010a). 
The increase in UCP3 expression in response to H2O2 or HNE treatment that we found in 
this work, together with its proposed function in the control of mitochondrial ROS 
production, led us to investigate the potential implication of the redox-sensitive transcription 
factor Nrf2 in UCP3 upregulation under oxidative stress conditions. Thus, the treatment with 
sub-toxic concentrations of H2O2 or HNE induced the nuclear accumulation of Nrf2 in C2C12 
and HL-1 cells. Our results are consistent with previous reports showing that Nrf2 signalling 
plays an important role in H2O2-induced protection against oxidative injury in cardiomyocytes 
(Purdom-Dickinson et al. 2007). They also agree with the notion that Nrf2 is a key 
transcriptional regulator for the HNE-mediated induction of antioxidant defences in the same 
cell type and in isolated perfused hearts (Zhang et al. 2010). However, the mechanism by which 
HNE induces the nuclear accumulation of Nrf2 in our experiments remains to be clarified. It is 
well-known that specific cysteine residues (Cys151, Cys273 and Cys288) in Keap1 (the 
cytosolic repressor of Nrf2) act as a sensor for oxidative stress, and modification of these 
residues leads to a conformational change in Keap1, with the subsequent release of Nrf2 
(Kobayashi et al. 2006). Our experiments using N-acetylcysteine (NAC) indicate that Nrf2 
nuclear accumulation and UCP3 upregulation are prevented in the presence of this 
antioxidant, probably due to the ability of NAC to reduce the oxidized cysteines in Keap1. This 
would prevent Nrf2 activation and therefore its effect on UCP3 expression. 
We observed increases in Nrf2 mRNA levels after H2O2 or HNE treatment that were 
accompanied by enhanced protein expression in the nuclear fraction. Importantly, Nrf2 
nuclear accumulation correlated with increased transcriptional activity, since the expression 
levels of its target gene HO-1 were also increased, demonstrating Nrf2 activation under H2O2 
or HNE treatment. Under these conditions, the degradation of Nrf2 by the proteasome system 
is inhibited and its nuclear translocation allows the binding of the protein to the ARE 
sequences of its target genes, which leads to the activation of a variety of antioxidant defences, 
including HO-1 and, as found in this work, UCP3. 
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There are several potential sites for Nrf2 binding in the Ucp3 promoter. One of them consists 
of a region containing an ARE sequence highly conserved between mammalian species. Our 
ChIP experiments revealed the specific binding of Nrf2 to this conserved ARE region after 
H2O2 or HNE treatment. Moreover, luciferase reporter experiments demonstrated that Nrf2 
binding to the Ucp3 promoter induces downstream gene transcription. Importantly, we 
showed that the ARE sequence is absolutely necessary for oxidative stress-induced 
transcription, as the mutated form of the ARE did not result in increased transcription.  
It is worth noting that the basal levels of luciferase expression in cells transfected with the 
plasmid containing the longer Ucp3 promoter sequence were higher than those detected in cells 
transfected with the plasmid containing the shorter sequence of the Ucp3 promoter. This could 
reflect the fact that other factors could bind the promoter at specific sites and increase the 
basal transcription of the gene. Indeed, the transcriptional regulation of Ucp3 by factors such 
as PPARs and the myogenic regulatory factor MyoD (Solanes et al. 2003), thyroid hormones 
(Solanes et al. 2005) and glucocorticoids (Amat et al. 2007), have been described.  
The involvement of Nrf2 on UCP3 upregulation under oxidative stress was confirmed by 
Nrf2 mRNA interference experiments. The results showed that UCP3 was not induced in the 
absence of Nrf2 under conditions of oxidative stress. Therefore, the absence of Nrf2 via RNA 
interference, prevents the H2O2 or HNE-induced increase in UCP3 expression, confirming the 
involvement of Nrf2 in this process. However, the possibility that H2O2 or HNE are also acting 
on UCP3 stability cannot be excluded. 
Our results provide direct biochemical evidence that, in response to oxidative stress, Nrf2 
interacts with and activates a specific antioxidant response element (ARE) in the Ucp3 
promoter, demonstrating that UCP3 is induced via Nrf2 under oxidative stress conditions. 
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2. UCP3 UPREGULATION MEDIATED BY NRF2 PROTECTS AGAINST 
OXIDATIVE DAMAGE AND INCREASES CELL SURVIVAL 
The results obtained using Ucp3-silenced HL-1 cells treated with H2O2, showed that these 
cells have enhanced levels of oxidative stress compared to control cells. In accordance with 
this, the absence of UCP3 led to an increase in cell death after H2O2 or HNE treatment. These 
findings support a protective role for the protein against oxidative stress.  
Our bioenergetic analysis of siUCP3 and scrambled (Scr) control HL-1 cells in the absence 
of treatment, revealed comparable levels of both basal respiration and proton leak in the 
absence or presence of UCP3. This is consistent with the similar proton leak reported for 
UCP3-KO and wild-type (WT) mice under basal conditions (Cadenas et al. 2002, Nabben et 
al. 2011), and supports the accepted view that UCP3 does not catalyse the basal proton 
conductance unless appropriately activated (Brand and Esteves 2005). Indeed, the 
physiologically-induced upregulation of UCP3 often fails to increase mitochondrial basal 
uncoupling (Bugger et al. 2008, Cadenas et al. 1999, Crescenzo et al. 2003).  
After the treatment with H2O2 or HNE, the increment in UCP3 levels was accompanied by 
enhanced basal respiration and proton conductance in Scr control cells. However, the addition 
of H2O2 did not significantly increase basal respiration or proton leak in siUCP3 cells, 
indicating that the enhanced respiration observed in control cells was specifically mediated by 
UCP3. The bioenergetic analysis of Nrf2-silenced HL-1 cells under H2O2 exposure reproduced 
similar results, since UCP3 was not induced in the absence of Nrf2 under conditions of 
oxidative stress. In contrast to H2O2 treatment, basal respiration and proton leak after HNE 
exposure were still elevated in siUCP3 cells, although the increase in proton leak was 
significantly reduced compared to Scr cells. Therefore, the elevated proton leak after HNE 
addition can be partially attributed to UCP3. According to our data, the contribution of UCP3 
to HNE-induced proton leak is around 21%. This observation is similar to the reported 
contribution of UCP3 to HNE-induced proton leak in mouse skeletal muscle mitochondria 
(Aguirre and Cadenas 2010, Echtay et al. 2003, Parker et al. 2008a). 
The effects of UCP3 upregulation on ATP turnover, maximal respiration and respiratory 
reserve capacity of HL-1 cells, also showed some differences depending on the treatment. The 
induction of UCP3 after H2O2 exposure did not significantly modify ATP turnover, maximal 
respiration or respiratory reserve capacity. By contrast, after HNE addition, the maximal 
respiration was dramatically decreased, even more so in siUCP3 cells, and therefore the reserve 
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capacity of the cells was inexistent. This exhaustion of the reserve capacity by HNE treatment 
does not depend on UCP3, as it occurs in both Scr and siUCP3 cells, and it is in agreement with 
reported data in rat neonatal cardiomyocytes (Hill et al. 2009a). Surprisingly, in both Scr and 
Ucp3-silenced cells, ATP turnover was significantly elevated after HNE addition, also in 
agreement with the mentioned report (Hill et al., 2009), although this result was independent 
of the presence of UCP3 as well. HNE levels are increased in several myocardial pathologies 
(Eaton et al. 1999, Hill et al. 2009b, Mak et al. 2000, Nakamura et al. 2002, Srivastava et al. 
2007), and the activation of critical enzymes for HNE detoxification protects the heart from 
ischemic injury (Chen et al. 2008, Churchill et al. 2009). Our data suggest that the decrease in 
respiratory reserve capacity promoted by HNE could contribute to tissue damage and 
dysfunction. 
Our results support the hypothesis that, in the presence of activators, UCP3 enhances 
proton conductance slightly lowering ΔΨm (mild uncoupling), which could led in turn to 
decreased mitochondrial ROS production and enhanced cell survival (Brand and Esteves 2005, 
Mailloux and Harper 2011). In fact, the observation of the cells by microscopy after treatment 
with H2O2 or HNE clearly showed augmented cell death in Ucp3- or Nrf2-silenced cells, 
confirming the role of this protein in the protection against oxidative stress. 
3. UCP3 EXPRESSION AND NRF2 NUCLEAR ACCUMULATION 
INCREASE AFTER ISCHEMIA-REPERFUSION IN THE ISOLATED 
PERFUSED MOUSE HEART: CARDIOPROTECTIVE ROLE OF UCP3 
AND NRF2 
We confirmed the physiological relevance of our findings by studying a condition known to 
increase ROS generation, ischemia-reperfusion (IR), in the isolated perfused mouse heart. Our 
results show that IR increases both Nrf2 nuclear accumulation and UCP3 expression, 
suggesting that Nrf2-mediated UCP3 upregulation might play an important role in the 
protection against oxidative damage during IR.  
Several studies have demonstrated that the Nrf2/ARE pathway is activated by oxidative 
stress, and that this activation protects against cell death. Indeed, mild oxidative stress, 
including sub-toxic H2O2, strongly activates astrocytic Nrf2/ARE-dependent gene expression, 
which in turn contributes to neuroprotective ischemic preconditioning (IPC) (Bell et al. 2011a, 
Bell et al. 2011b). Moreover, there is evidence that high concentrations of reactive aldehydes 
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such as HNE are responsible for much of the damage elicited by cardiac IR injury (Conklin et 
al. 2007), while sub-lethal concentrations of aldehydes stimulate stress resistance pathways to 
achieve cardioprotection (Zhang et al. 2010). Thus, the pre-treatment with an activator of an 
aldehyde-detoxifying enzyme, aldehyde dehydrogenase-2 (ALDH2), reduced infarct size by 
60% in a rat model of IR injury (Chen et al. 2008). Moreover, Nrf2 activation and Nrf2-
dependent antioxidant gene expression were demonstrated in an in vivo model of IR damage, 
providing evidence for the involvement of ROS in the reoxygenation-specific activation of Nrf2 
(Leonard et al. 2006). Furthermore, sub-lethal concentrations (5 µM) of HNE prime 
cardiomyocytes to become resistant to cytotoxic concentrations of HNE via Nrf2-mediated 
gene expression and GSH biosynthesis, thereby conferring protection against IR injury (Zhang 
et al. 2010). 
We observed an upregulation of UCP3 after IR. Recently, UCP2 and UCP3 have been 
reported to increase in rat hearts subjected to IR (Safari et al. 2014). In this paper, the authors 
show that, whereas the effect of IR on UCP2 protein is a local process, UCP3 protein increases 
in the whole heart. The expression of UCP3 has also been studied in human failing hearts, but 
in this case the conclusion is unclear. Although there is evidence of increased levels of cardiac 
UCP3 in patients with heart failure (Murray et al. 2004), other data showed unchanged UCP3 
gene expression in human failing hearts compared to non-failing hearts (Razeghi et al. 2001). 
This disagreement might be caused by the measurement of protein levels versus Ucp3 mRNA 
or by the differences in the type of samples obtained from the patients.  
Our description of a novel signalling pathway mediated by Nrf2 and involving the 
mitochondrial protein UCP3, which is implicated in the control of O2·− production, is highly 
relevant to IR, a situation in which there is a burst of ROS generation. The activation of UCPs 
and the subsequent modest mitochondrial depolarization could diminish O2·− production in 
cardiac ischemia, thus conferring ischemia tolerance (Cadenas et al. 2010, Sack 2006). Indeed, 
there are some reports suggesting a protective role of UCP-mediated uncoupling against IR 
injury. Thus, mitochondrial UCP1 protects against IR injury when expressed ectopically in 
cardiac-derived H9c2 cells (Bienengraeber et al. 2003) and in the hearts of transgenic mice 
(Hoerter et al. 2004). In rat neonatal cardiomyocytes, UCP2 overexpression does not have 
intrinsic uncoupling activity but it confers tolerance to oxidative stress by diminishing 
mitochondrial Ca2+ overload and reducing ROS generation (Teshima et al. 2003). Additionally, 
there is an inverse relationship between ROS and UCP3 levels in cardiomyocytes, and proper 
UCP3 expression protects against restrain stress-induced myocardial injury in rats (Wang et 
al. 2010). 
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Our results show a significantly greater infarct size after IR in UCP3-KO than in WT hearts, 
which suggest that hearts lacking UCP3 are less protected and, therefore, result more damaged 
than those in which the protein is present. Taking into account that UCP3 was upregulated in 
the hearts of WT mice after IR, these results strongly suggest that UCP3 plays a protective role 
against IR injury. This conclusion was confirmed using another indicator of cardiac tissue 
damage, the activity levels of creatine kinase (CK) released in the coronary effluent during 
reperfusion. This parameter showed the same pattern, confirming that UCP3-KO mice present 
greater damage than their WT counterparts. The basal measurement of CK (previous to 
ischemia) was comparable in both groups, discarding basal damage in UCP3-KO hearts, and 
reinforcing the idea that the increased cardiac damage observed in these hearts is caused by IR.  
During the performance of these experiments, an article was published to show that UCP3 
plays a critical role in cardioprotection against IR injury (Ozcan et al. 2013). The authors 
analysed physiological parameters such as contractile function, and reported that hearts from 
UCP3-KO mice have poorer recovery of left-ventricular function compared to WT hearts after 
ex vivo IR. Likewise, in vivo occlusion of the left coronary artery resulted in two-fold larger 
infarcts in UCP3-KO compared to WT mice, in agreement with our findings in isotated 
perfused hearts.  
We performed ex vivo experiments in hearts of Nrf2-KO mice and obtained similar results. 
These hearts showed a significantly greater infarction after IR than the WT hearts. The 
increased cardiac damage was confirmed by the measurement of CK released in the coronary 
effluent during reperfusion, which was elevated in Nrf2-KO compared to WT hearts. 
Importantly, the basal measurement of CK (previous to ischemia) was higher in Nrf2-KO 
hearts, contrarily to the case of UCP3-KO hearts, indicating that there is some degree of basal 
damage in these hearts. To confirm this result, however, the infarct size of the hearts after 
control perfusion only, would have to be determine in both WT and Nrf2-KO mice, and 
therefore the conclusion that the basal cardiac damage is increased in these mice should be 
taken with caution. 
On the whole, these results appear to be in agreement with the proposed role for UCP3 in 
cardioprotection, although they bring some discrepancy with reported work in which the 
worse outcome for the Nrf2-KO compared to the WT hearts is not evident as determined by 
ventricular recovery function and lactate dehydrogenase (LDH) release (Zhang et al. 2010). In 
this paper, the authors manifest confusion by their findings and, considering all their results 
 
 
116 
 
 DISCUSSION 
together, they conclude nonetheless that Nrf2 is essential for cardioprotection mediated by 
HNE. 
4. UCP3 IS INVOLVED IN THE CARDIOPROTECTIVE PHENOMENON 
OF ISCHEMIC PRECONDITIONING 
Ischemic preconditioning (IPC) is a protective phenomenon evoked by transient non-lethal 
tissue ischemia prior to a prolonged ischemic insult (Murry et al., 1986). Although IPC 
protection has been well documented since its discovery, the specific mechanisms involved are 
not completely understood despite intense investigation (Bell and Yellon 2012, Hausenloy and 
Yellon 2011, Semenza 2011, Shi and Vinten-Johansen 2012). Several protective pathways have 
been described (Hausenloy et al. 2005, Suleman et al. 2008). In addition, upregulation of UCP2 
and UCP3 has been observed in the delayed preconditioned heart (McLeod et al. 2005), 
suggesting a role for these proteins in this phenomenon. 
Our experiments in isolated preconditioned hearts show that IPC strongly induces UCP3 
expression and Nrf2 nuclear accumulation. The induction is higher than that observed after IR 
in non-preconditioned hearts, and clearly implicates these proteins in the IPC phenomenon. 
UCP3 and Nrf2 upregulation was detected after the complete IPC plus IR protocol, and not 
after IPC followed solely by reperfusion or by ischemia. Since the former protocol was 1 h 
longer than the others, we cannot discard that this extra time is required for new protein 
synthesis. 
Our results show that IPC decreases the infarct size after IR in WT hearts, as expected. 
However, mice lacking UCP3 do not show this protective effect, which clearly demonstrates 
the involvement of UCP3 in IPC. These results agree with those recently published by Ozcan 
and col. (Ozcan et al. 2013). However, the precise mechanism by which UCP3 confers 
protection remains to be determined. 
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In summary, in this thesis we present evidence of a novel antioxidant pathway mediated by 
the redox-sensitive transcription factor Nrf2 and involving the mitochondrial protein UCP3. 
Our data support a model in which the addition of oxidants or lipid peroxidation products, or 
conditions leading to ROS formation such as IR, activates Nrf2, which translocates to the 
nucleus and binds to the Ucp3 promoter, thereby enhancing its expression. The increase in 
UCP3 expression, together with UCP3 protein activation by O2·− and HNE, enhances proton 
conductance, lowering the membrane potential and decreasing mitochondrial superoxide 
generation. This effect is reflected into increased cell survival under conditions of oxidative 
stress, and cardioprotection against IR injury in the isolated perfused mouse heart. Likewise, 
this protective pathway might be involved in IPC. Therefore, this novel pathway is a plausible 
therapeutic target for novel strategies aimed at preventing oxidative damage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure D1. The treatment with H2O2, HNE, or conditions leading to ROS formation such as IR, increases UCP3 
expression via Nrf2, promoting cell survival under conditions of oxidative stress. Model showing the activation 
and nuclear translocation of Nrf2 induced by oxidative stress. The binding of Nrf2 to an ARE within the Ucp3 
promoter increases UCP3 expression, whereas HNE also increases directly UCP3 activity. Increased UCP3 
expression together with protein activation induces a slight decrease in the membrane potential (mild 
uncoupling) and an ensuing decrease in O2·− production. This mechanism promotes cell survival under conditions 
of oxidative stress. 
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1. UCP3 expression is regulated in response to oxidative stress. Thus, both mRNA and 
protein levels are upregulated after the treatment with hydrogen peroxide (H2O2) or 4-
hydroxy-2-nonenal (HNE) in cell lines from mouse heart and skeletal muscle. 
 
2. The transcription factor Nrf2 is involved in the upregulation of UCP3 under oxidative 
stress conditions. Nrf2 binds to a specific ARE sequence conserved in the Ucp3 promoter 
to activate Ucp3 transcription in response to oxidative stress.  
 
3. Nrf2-mediated UCP3 upregulation, as well as its activation by superoxide and HNE, 
enhance mitochondrial proton leak diminishing ROS generation and promoting cell 
survival. 
 
4. Myocardial ischemia-reperfusion (IR) in isolated perfused mouse hearts increases 
UCP3 expression and Nrf2 nuclear accumulation, effects that are potentiated in ischemic 
preconditioned hearts. 
 
5. Both UCP3 and Nrf2 protect the heart from the damaging effects of IR, since hearts 
from mice lacking any of these proteins exhibit more damage than those from wild-type 
mice. 
 
6. UCP3 takes part in the protective programme of ischemic preconditioning (IPC) in 
isolated perfused mouse hearts, since both preconditioned and non-preconditioned 
hearts from UCP3-KO mice have similar damage after IR. 
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1. La expresión de UCP3 está regulada en respuesta al estrés oxidativo. Así, tanto el mRNA 
como la proteína se encuentran incrementados tras el tratamiento con peróxido de 
hidrógeno (H2O2) o 4-hidroxi-2-nonenal (HNE) en líneas celulares de corazón y músculo 
esquelético de ratón. 
 
2. El factor de transcripción Nrf2 está involucrado en la inducción de UCP3 en 
condiciones de estrés oxidativo. Nrf2 se une a una secuencia específica ARE conservada 
en el promotor de Ucp3  para activar la transcripción del gen en respuesta al estrés 
oxidativo. 
 
3. La inducción de UCP3 mediada por Nrf2, así como su activación por superóxido y HNE, 
aumentan la fuga de protones (‘proton leak’) mitocondrial, disminuyendo así la 
generación de ROS y promoviendo la supervivencia celular. 
 
4. La isquemia-reperfusión cardíaca (IR) en corazones aislados perfundidos de ratón 
aumenta la expresión de UCP3 y la acumulación nuclear de Nrf2, efectos que están 
potenciados en los corazones precondicionados. 
 
5. Tanto UCP3 como Nrf2 protegen al corazón frente a los efectos perjudiciales de la IR, 
ya que los corazones de ratones que carecen de alguna de estas proteínas muestran más 
daño quelos de ratones de tipo silvestre. 
 
6. UCP3 participa en el programa protector del precondicionamiento isquémico (IPC) en 
corazones aislados perfundidos de ratón, ya que los corazones de ratones UCP3-KO 
precondicionados y no precondicionados presentan un daño similar tras IR. 
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